10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 28, 2021

or 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 0-12933 

___________________________________________________________

LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________________

Delaware	94-2634797
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

4650 Cushing Parkway, Fremont, California 94538

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (510) 572-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share	LRCX	The Nasdaq Stock Market
		(Nasdaq Global Select Market)

__________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of April 26, 2021, the Registrant had 142,619,346 shares of Common Stock outstanding.

LAM RESEARCH CORPORATION

TABLE OF CONTENTS

		Page No.
	PART I. Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Statements of Operations for the three and nine months ended March 28, 2021 and March 29, 2020	3
	Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended March 28, 2021, and March 29, 2020	4
	Condensed Consolidated Balance Sheets as of March 28, 2021, and June 28, 2020	5
	Condensed Consolidated Statements of Cash Flows for the nine months ended March 28, 2021, and March 29, 2020	6
	Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 28, 2021, and March 29, 2020	7
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	34
Item 4.	Controls and Procedures	35
	PART II. Other Information
Item 1.	Legal Proceedings	36
Item 1A.	Risk Factors	36
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 3.	Defaults Upon Senior Securities	49
Item 4.	Mine Safety Disclosures	49
Item 5.	Other Information	49
Item 6.	Exhibits	50
Signatures		51

PART I. FINANCIAL INFORMATION

ITEM 1.    Financial Statements

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Revenue	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872
Cost of goods sold	2,067,523		1,336,618		5,590,866		3,924,511
Gross margin	1,780,131		1,167,007		4,890,105		3,328,361
Research and development	381,120		307,914		1,111,659		913,602
Selling, general, and administrative	203,703		164,979		612,350		496,679
Total operating expenses	584,823		472,893		1,724,009		1,410,281
Operating income	1,195,308		694,114		3,166,096		1,918,080
Other expense, net	(35,320)		(64,619)		(104,053)		(91,271)
Income before income taxes	1,159,988		629,495		3,062,043		1,826,809
Income tax expense	(88,867)		(54,714)		(298,242)		(271,729)
Net income	$	1,071,121	$	574,781	$	2,763,801	$	1,555,080
Net income per share:
Basic	$	7.51	$	3.96	$	19.20	$	10.75
Diluted	$	7.41	$	3.88	$	18.94	$	10.39
Number of shares used in per share calculations:
Basic	142,676		145,301		143,925		144,654
Diluted	144,609		148,165		145,923		149,648

See Notes to Condensed Consolidated Financial Statements

3

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

(unaudited)

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Net income	$	1,071,121	$	574,781	$	2,763,801	$	1,555,080
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(13,701)		(18,225)		20,231		(19,412)
Cash flow hedges:
Net unrealized gains (losses) during the period	8,024		(29,456)		12,546		(26,068)
Net (gains) losses reclassified into net income	(207)		(924)		843		1,810
	7,817		(30,380)		13,389		(24,258)
Available-for-sale investments:
Net unrealized losses during the period	(1,623)		(4,129)		(3,667)		(6,842)
Net losses reclassified into net income	162		27		727		1,010
	(1,461)		(4,102)		(2,940)		(5,832)
Defined benefit plans, net change in unrealized component	174		278		234		856
Other comprehensive (loss) income, net of tax	(7,171)		(52,429)		30,914		(48,646)
Comprehensive income	$	1,063,950	$	522,352	$	2,794,715	$	1,506,434

See Notes to Condensed Consolidated Financial Statements

4

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

	March 28, 2021		June 28, 2020
	(unaudited)		(1)
ASSETS
Cash and cash equivalents	$	3,673,366	$	4,915,172
Investments	2,116,101		1,795,080
Accounts receivable, less allowance of $5,191 as of March 28, 2021, and $5,465 as of June 28, 2020	2,809,068		2,097,099
Inventories	2,552,032		1,900,024
Prepaid expenses and other current assets	171,703		146,160
Total current assets	11,322,270		10,853,535
Property and equipment, net	1,279,836		1,071,499
Restricted cash and investments	253,460		253,911
Goodwill	1,489,990		1,484,436
Intangible assets, net	143,264		168,532
Other assets	796,093		727,134
Total assets	$	15,284,913	$	14,559,047
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	760,942	$	592,387
Accrued expenses and other current liabilities	1,292,174		1,272,655
Deferred profit	733,783		457,523
Current portion of long-term debt and finance lease obligations	825,434		839,877
Total current liabilities	3,612,333		3,162,442
Long-term debt and finance lease obligations, less current portion	4,991,613		4,970,848
Income taxes payable	924,629		909,709
Other long-term liabilities	381,505		332,559
Total liabilities	9,910,080		9,375,558
Commitments and contingencies
Temporary equity, convertible notes	3,217		10,995
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding	—		—
Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 28, 2021 and June 28, 2020; issued and outstanding, 142,607 shares at March 28, 2021, and 145,331 shares at June 28, 2020	143		145
Additional paid-in capital	6,922,023		6,695,858
Treasury stock, at cost; 150,111 shares at March 28, 2021, and 145,432 shares at June 28, 2020	(15,212,934)		(12,949,889)
Accumulated other comprehensive loss	(63,297)		(94,211)
Retained earnings	13,725,681		11,520,591
Total stockholders’ equity	5,371,616		5,172,494
Total liabilities and stockholders’ equity	$	15,284,913	$	14,559,047

(1) Derived from audited financial statements

See Notes to Condensed Consolidated Financial Statements

5

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (unaudited)

	Nine Months Ended
	March 28, 2021		March 29, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	2,763,801		$	1,555,080
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	228,754		197,442
Deferred income taxes	(5,448)		74,516
Equity-based compensation expense	163,843		136,044
Amortization of note discounts and issuance costs	4,251		4,611
Other, net	6,143		11,510
Changes in operating assets and liabilities	(1,009,116)		(665,800)
Net cash provided by operating activities	2,152,228		1,313,403
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(244,474)		(152,685)
Purchases of available-for-sale securities	(3,242,741)		(1,889,823)
Maturities of available-for-sales securities	1,951,037		1,163,555
Sales of available-for-sale securities	956,261		1,065,618
Other, net	(35,873)		(540)
Net cash (used for) provided by investing activities	(615,790)		186,125
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(40,014)		(664,589)
Proceeds from borrowings on revolving credit facility	—		1,250,000
Treasury stock purchases	(2,266,449)		(1,328,632)
Dividends paid	(541,607)		(489,099)
Reissuance of treasury stock related to employee stock purchase plan	41,434		38,447
Proceeds from issuance of common stock	23,272		6,215
Other, net	(1,844)		328
Net cash used for financing activities	(2,785,208)		(1,187,330)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	6,513		(9,853)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(1,242,257)		302,345
Cash, cash equivalents, and restricted cash at beginning of period	5,169,083		3,913,396
Cash, cash equivalents, and restricted cash at end of period	$	3,926,826	$	4,215,741
Schedule of non-cash transactions:
Accrued payables for stock repurchases	5,855		295
Accrued payables for capital expenditures	80,215		29,690
Dividends payable	185,390		167,740
Transfers of inventory to property and equipment, net	59,882		34,155
Reconciliation of cash, cash equivalents, and restricted cash	March 28, 2021		March 29, 2020
Cash and cash equivalents	$	3,673,366	$	3,961,586
Restricted cash and investments	253,460		254,155
Total cash, cash equivalents, and restricted cash	$	3,926,826	$	4,215,741

See Notes to Condensed Consolidated Financial Statements

6

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

(unaudited)

	Three Months Ended
	March 28, 2021
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at December 27, 2020	143,205	$	143	$	6,854,681	$	(14,135,555)	$	(56,126)	$	12,839,890	$	5,503,033
Issuance of common stock	848	1		9,625		—		—		—		9,626
Purchase of treasury stock	(1,731)	(1)		—		(1,077,379)		—		—		(1,077,380)
Equity-based compensation expense	—	—		55,746		—		—		—		55,746
Effect of conversion of convertible notes	285	—		(327)		—		—		—		(327)
Reclassification from temporary to permanent equity	—	—		2,298		—		—		—		2,298
Net income	—	—		—		—		—		1,071,121		1,071,121
Other comprehensive loss	—	—		—		—		(7,171)		—		(7,171)
Cash dividends declared ($1.30 per common share)	—	—		—		—		—		(185,330)		(185,330)
Balance at March 28, 2021	142,607	$	143	$	6,922,023	$	(15,212,934)	$	(63,297)	$	13,725,681	$	5,371,616
	Nine Months Ended
	March 28, 2021
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at June 28, 2020	145,331	$	145	$	6,695,858	$	(12,949,889)	$	(94,211)	$	11,520,591	$	5,172,494
Issuance of common stock	1,053	1		23,271		—		—		—		23,272
Purchase of treasury stock	(4,887)	(4)		—		(2,272,218)		—		—		(2,272,222)
Reissuance of treasury stock	207	—		32,261		9,173		—		—		41,434
Equity-based compensation expense	—	—		163,843		—		—		—		163,843
Effect of conversion of convertible notes	903	1		(988)		—		—		—		(987)
Reclassification from temporary to permanent equity	—	—		7,778		—		—		—		7,778
Adoption of ASU 2018-18 1	—	—		—		—		—		1,157		1,157
Net income	—	—		—		—		—		2,763,801		2,763,801
Other comprehensive income	—	—		—		—		30,914		—		30,914
Cash dividends declared ($3.90 per common share)	—	—		—		—		—		(559,868)		(559,868)
Balance at March 28, 2021	142,607	$	143	$	6,922,023	$	(15,212,934)	$	(63,297)	$	13,725,681	$	5,371,616
(1) Refer to Note 2 - Recent Accounting Pronouncements for more information regarding this Financial Accounting Standards Board (FASB) Accounting Standard Updates.

See Notes to Condensed Consolidated Financial Statements

7

	Three Months Ended
	March 29, 2020
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at December 29, 2019	142,462	$	142	$	6,528,821	$	(12,673,292)	$	(60,247)	$	10,584,005	$	4,379,429
Issuance of common stock	1,047	1		1,713		—		—		—		1,714
Purchase of treasury stock	(1,576)	(1)		—		(245,438)		—		—		(245,439)
Equity-based compensation expense	—	—		47,414		—		—		—		47,414
Effect of conversion of convertible notes	3,223	3		(26,884)		—		—		—		(26,881)
Reclassification from temporary to permanent equity	—	—		26,758		—		—		—		26,758
Net income	—	—		—		—		—		574,781		574,781
Other comprehensive loss	—	—		—		—		(52,429)		—		(52,429)
Cash dividends declared ($1.15 per common share)	—	—		—		—		—		(167,740)		(167,740)
Balance at March 29, 2020	145,156	$	145	$	6,577,822	$	(12,918,730)	$	(112,676)	$	10,991,046	$	4,537,607
	Nine Months Ended
	March 29, 2020
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at June 30, 2019	144,433	$	144	$	6,409,405	$	(11,602,573)	$	(64,030)	$	9,930,919	$	4,673,865
Issuance of common stock	1,230	1		6,214		—		—		—		6,215
Purchase of treasury stock	(5,215)	(4)		—		(1,328,894)		—		—		(1,328,898)
Reissuance of treasury stock	296	—		25,710		12,737		—		—		38,447
Equity-based compensation expense	—	—		136,044		—		—		—		136,044
Effect of conversion of convertible notes	4,412	4		(37,444)		—		—		—		(37,440)
Reclassification from temporary to permanent equity	—	—		37,893		—		—		—		37,893
Adoption of ASU 2016-02	—	—		—		—		—		3,018		3,018
Net income	—	—		—		—		—		1,555,080		1,555,080
Other comprehensive loss	—	—		—		—		(48,646)		—		(48,646)
Cash dividends declared ($3.45 per common share)	—	—		—		—		—		(497,971)		(497,971)
Balance at March 29, 2020	145,156	$	145	$	6,577,822	$	(12,918,730)	$	(112,676)	$	10,991,046	$	4,537,607

See Notes to Condensed Consolidated Financial Statements

8

LAM RESEARCH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 28, 2021

(Unaudited)

NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 28, 2020, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 28, 2020 (the “2020 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 27, 2021 and includes 52 weeks. The quarters ended March 28, 2021 (the “March 2021 quarter”) and March 29, 2020 (the “March 2020 quarter”) included 13 weeks.

NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted

In June 2016, the Financial Accounting Standards Board (“FASB”) released Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326).” The amendment revises the impairment model to utilize an expected loss methodology in place of the previously used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The FASB issued a subsequent amendment to the initial guidance in April 2019 and November 2019 within ASU 2019-04 and ASU 2019-11, respectively. The adoption of these standards in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In November 2018, the FASB issued ASU 2018-18, “Collaborative Arrangements (Topic 808).” The amendment clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606 when the counterparty is a customer for a good or service that is a distinct unit of account. The amendment also precludes entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The adoption of this standard in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “ Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company has not yet applied the relief afforded by these standard amendments and is currently assessing contracts that will require modification due to reference rate reform to which these standard amendments may be applied.

9

Updates Not Yet Adopted or Effective

In August 2020, the FASB issued ASU No. 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. ASU 2020-06 also eliminates the treasury stock method to calculate diluted earnings per share and requires the if-converted method. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is required to adopt this standard in the first quarter of fiscal year 2023. The update permits the use of either the modified retrospective or fully retrospective method of transition. The Company does not expect adoption of this standard to have a material impact on its Consolidated Financial Statements related to the Company’s existing 2041 Notes (as defined in Note 12 - Long-Term Debt and Other Borrowings ).

NOTE 3 — REVENUE

Deferred Revenue

Revenue of $69.1 million and $427.2 million included in deferred revenue as of June 28, 2020 was recognized during the three and nine months ended March 28, 2021.

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 28, 2021 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years		Total
	(In thousands)
Deferred revenue	$	661,240	$	156,040	(1)	$	—	$	817,280

(1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Disaggregation of Revenue

The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution.

The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing.

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
System revenue	$	2,545,306	$	1,647,560	$	7,000,968	$	4,759,881
Customer support-related revenue and other	1,302,348		856,065		3,480,003		2,492,991
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant product line.

10

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
China	$	1,217,427	$	792,412	$	3,600,281	$	2,142,366
Korea	1,195,711		589,072		2,664,493		1,503,733
Taiwan	545,719		515,485		1,576,109		1,587,848
Japan	262,913		239,751		999,462		721,664
Southeast Asia	260,360		62,800		829,157		460,723
United States	184,887		215,015		460,271		622,399
Europe	180,637		89,090		351,198		214,139
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Memory	62	%	56	%	62	%	57	%
Foundry	31	%	31	%	31	%	31	%
Logic/integrated device manufacturing	7	%	13	%	7	%	12	%

NOTE 4 — EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Equity-based compensation expense	$	55,746	$	47,414	$	163,843	$	136,044
Income tax benefit recognized related to equity-based compensation expense	$	44,077	$	24,457	$	63,866	$	38,736

11

NOTE 5 — OTHER EXPENSE, NET

The significant components of other expense, net, are as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Interest income	$	4,209	$	18,856	$	15,964	$	76,094
Interest expense	(52,236)		(41,580)		(156,902)		(128,190)
Gains (losses) on deferred compensation plan-related assets, net	7,520		(33,828)		44,654		(20,135)
Foreign exchange gains (losses), net	541		480		(4,597)		(2,336)
Other, net	4,646		(8,547)		(3,172)		(16,704)
	$	(35,320)	$	(64,619)	$	(104,053)	$	(91,271)

NOTE 6 — INCOME TAX EXPENSE

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 28, 2021			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Income tax expense	$	88,867		$	54,714		$	298,242		$	271,729
Effective tax rate	7.7		%	8.7		%	9.7		%	14.9		%

The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three and nine months ended March 28, 2021 and the three and nine months ended March 29, 2020 was primarily due to income in lower tax jurisdictions, stock-based compensation excess tax benefits, and a cumulative income tax benefit reversal due to a court ruling in the nine months ended March 29, 2020.

The Internal Revenue Service (“IRS”) is examining the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of March 28, 2021, no significant adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur.

The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its uncertain tax positions as a result of tax examinations or lapses of statutes of limitations. The change in uncertain tax positions as a result of lapses of statutes of limitations may range up to $7.4 million.

12

NOTE 7 — NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, and convertible notes. Refer to Note 12 - Long-term Debt and Other Borrowings for additional information regarding the Company’s convertible notes. The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands, except per share data)
Numerator:
Net income	$	1,071,121	$	574,781	$	2,763,801	$	1,555,080
Denominator:
Basic average shares outstanding	142,676		145,301		143,925		144,654
Effect of potential dilutive securities:
Employee stock plans	1,415		1,453		1,273		1,390
Convertible notes	518		1,411		725		3,604
Diluted average shares outstanding	144,609		148,165		145,923		149,648
Net income per share - basic	$	7.51	$	3.96	$	19.20	$	10.75
Net income per share - diluted	$	7.41	$	3.88	$	18.94	$	10.39

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:

	Three Months Ended		Nine Months Ended
	March 28, 2021	March 29, 2020	March 28, 2021	March 29, 2020
	(in thousands)
Options and RSUs	120	40	40	13

NOTE 8 — FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other expense, net in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses associated with market valuation changes, unrelated to credit losses, reported as a separate component of accumulated other comprehensive income (loss), net of tax; and credit losses, if any, recognized as other expense, net in the Condensed Consolidated Statements of Operations.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

13

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company engages with pricing vendors to provide fair values for a majority of its Level 1 and Level 2 investments. The vendors provide either a quoted market price in an active market or use observable inputs without applying significant adjustments in their pricing. Significant observable inputs include interest rates and yield curves observable at commonly quoted intervals, volatility and credit risks. The fair value of derivative contracts is determined using observable market inputs such as the foreign currency rates, forward rate curves, currency volatility and interest rates and considers nonperformance risk of the Company and its counterparties.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. Refer to Note 12 - Long-Term Debt and Other Borrowings for additional information regarding the fair value of the Company’s senior notes and convertible senior notes.

Investments

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 28, 2021, and June 28, 2020:

	March 28, 2021
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	753,473	$	—	$	—	$	753,473	$	750,040	$	—	$	3,433	$	—
Time deposits	1,349,934		—		—		1,349,934		1,099,907		—		250,027		—
Level 1:
Money market funds	1,638,280		—		—		1,638,280		1,638,280		—		—		—
U.S. Treasury and agencies	385,461		209		(13)		385,657		—		385,657		—		—
Mutual funds	84,377		10,471		(105)		94,743		—		—		—		94,743
Level 1 Total	2,108,118		10,680		(118)		2,118,680		1,638,280		385,657		—		94,743
Level 2:
Government-sponsored enterprises	3,500		12		—		3,512		—		3,512		—		—
Foreign government bonds	47,099		43		(1)		47,141		—		47,141		—		—
Corporate notes and bonds	1,844,375		2,569		(633)		1,846,311		185,139		1,661,172		—		—
Mortgage backed securities — residential	6,279		74		—		6,353		—		6,353		—		—
Mortgage backed securities — commercial	12,264		33		(31)		12,266		—		12,266		—		—
Level 2 Total	1,913,517		2,731		(665)		1,915,583		185,139		1,730,444		—		—
Total	$	6,125,042	$	13,411	$	(783)	$	6,137,670	$	3,673,366	$	2,116,101	$	253,460	$	94,743

14

	June 28, 2020
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	977,862	$	—	$	—	$	977,862	$	973,978	$	—	$	3,884	$	—
Time deposits	2,244,655		—		—		2,244,655		1,994,628		—		250,027		—
Level 1:
Money market funds	1,709,350		—		—		1,709,350		1,709,350		—		—		—
U.S. Treasury and agencies	552,088		373		(9)		552,452		76,992		475,460		—		—
Mutual funds	68,784		4,571		(928)		72,427		—		—		—		72,427
Level 1 Total	2,330,222		4,944		(937)		2,334,229		1,786,342		475,460		—		72,427
Level 2:
Government-sponsored enterprises	31,442		12		—		31,454		25,999		5,455		—		—
Foreign government bonds	10,693		28		(5)		10,716		2,540		8,176		—		—
Corporate notes and bonds	1,405,615		5,344		(302)		1,410,657		131,685		1,278,972		—		—
Mortgage backed securities — residential	3,142		71		—		3,213		—		3,213		—		—
Mortgage backed securities — commercial	23,660		144		—		23,804		—		23,804		—		—
Level 2 Total	1,474,552		5,599		(307)		1,479,844		160,224		1,319,620		—		—
Total	$	7,027,291	$	10,543	$	(1,244)	$	7,036,590	$	4,915,172	$	1,795,080	$	253,911	$	72,427

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments.

Following the adoption of Accounting Standard Codification Topic 326 (see additional information in Note 2 - Recent Accounting Pronouncements), under Subtopic 326-30, the Company evaluates its investments with fair value less than amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference between fair value and amortized cost is recognized as a loss in the income statement. Where such sales are not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the result of credit losses, those amounts are recognized in the income statement. All other differences between fair value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the income statement during the three and nine months ended March 28, 2021.

The Company did not recognize any losses on investments due to other-than-temporary impairments during the three and nine months ended March 29, 2020. Gross realized gains/(losses) from sales of investments were insignificant in the three and nine months ended March 28, 2021 and March 29, 2020.

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions; as of March 28, 2021 there are no unrealized loss positions with a duration equal to or greater than twelve months:

	March 28, 2021
	Unrealized Losses Less than 12 Months
	Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	7,958	$	(13)
Municipal notes and bonds	6,468		(105)
Foreign government bonds	21,259		(1)
Corporate notes and bonds	540,915		(633)
Mortgage backed securities — commercial	7,599		(31)
	$	584,199	$	(783)

15

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 28, 2021:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,270,859	$	4,271,415
Due after one year through five years	967,417		969,055
Due in more than five years	48,916		48,984
	$	5,287,192	$	5,289,454

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.

Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of March 28, 2021 and June 28, 2020, the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be immaterial to the Condensed Consolidated Balance Sheets.

Cash Flow Hedges

The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items affect earnings.

In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive income (loss) and is amortized into income as the hedged item impacts earnings.

At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign exchange contracts due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not

16

believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately.

As of March 28, 2021 and June 28, 2020, the fair value of outstanding cash flow hedges was not material. Additionally, as of March 28, 2021, the Company had an immaterial net gain or loss accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges and interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 12 months.

The following table provides the total notional value of cash flow hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	328,737
Sell Contracts	352,034

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”), was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021				March 28, 2021
	Location of  Gain or (Loss) Recognized in or Reclassified into Net Income	Gain (Loss) Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income		Gain Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	15,285	$	(1,323)	$	6,948	$	(3,598)
Foreign Exchange Contracts	Cost of goods sold	(3,473)		1,355		3,429		3,073
Foreign Exchange Contracts	Research and Development	(1,319)		—		950		—
Foreign Exchange Contracts	Selling, general, and administrative	(1,741)		1,326		4,056		2,649
Interest Rate Contracts	Other expense, net	—		(962)		—		(2,871)
		$	8,752	$	396	$	15,383	$	(747)

		Three Months Ended				Nine Months Ended
		March 29, 2020				March 29, 2020
	Location of  Gain or (Loss) Recognized in or Reclassified into Income	Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income		Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	6,334	$	1,279	$	9,532	$	773
Foreign Exchange Contracts	Cost of goods sold	(2,589)		(186)		(3,656)		(2,086)
Foreign Exchange Contracts	Selling, general, and administrative	(1,394)		6		(1,859)		(887)
Interest Rate Contracts	Other expense, net	(40,901)		(36)		(38,507)		(106)
		$	(38,550)	$	1,063	$	(34,490)	$	(2,306)

Balance Sheet Hedges

The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other expense, net and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other expense, net. As of March 28, 2021 and June 28, 2020, the fair value of outstanding balance sheet hedges was not material.

17

The following table provides the total notional value of balance sheet hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	150,554
Sell Contracts	154,595

The effect of the Company’s balance sheet hedge derivative instruments on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Net Income		Loss Recognized in Net Income		Gain Recognized in Net Income		Loss Recognized in Net Income
		(in thousands)
Foreign Exchange Contracts	Other expense, net	$	2,992	$	(6,858)	$	6,895	$	(8,788)

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions, and, to date, no such counterparty has failed to meet its financial obligations to the Company.

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

NOTE 9 — INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Raw materials	$	1,437,563	$	1,161,961
Work-in-process	359,402		251,199
Finished goods	755,067		486,864
	$	2,552,032	$	1,900,024

18

NOTE 10 — GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.5 billion as of March 28, 2021 and June 28, 2020. As of March 28, 2021 and June 28, 2020, $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.

Intangible Assets

The following table provides the Company’s intangible assets, other than goodwill:

	March 28, 2021						June 28, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	630,278	$	(569,203)	$	61,075	$	630,137	$	(532,550)	$	97,587
Existing technology	669,302		(658,632)		10,670		668,992		(654,382)		14,610
Patents and other intangible assets	125,383		(53,864)		71,519		98,342		(42,007)		56,335
Total intangible assets	$	1,424,963	$	(1,281,699)	$	143,264	$	1,397,471	$	(1,228,939)	$	168,532

The Company recognized $17.9 million and $16.6 million in intangible asset amortization expense during the three months ended March 28, 2021 and March 29, 2020, respectively. The Company recognized $52.3 million and $49.3 million in intangible asset amortization expense during the nine months ended March 28, 2021 and March 29, 2020, respectively.

The estimated future amortization expense of intangible assets as of March 28, 2021, is reflected in the table below. The table excludes $13.9 million of capitalized costs for internal-use software that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2021 (remaining 3 months)	$	18,019
2022	68,138
2023	22,274
2024	12,089
2025	6,681
Thereafter	2,164
	$	129,365

NOTE 11 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Accrued compensation	$	442,188	$	402,401
Warranty reserves	156,059		117,839
Income and other taxes payable	99,021		215,652
Dividend payable	185,390		167,129
Other	409,516		369,634
	$	1,292,174	$	1,272,655

19

NOTE 12 — LONG-TERM DEBT AND OTHER BORROWINGS

As of March 28, 2021, and June 28, 2020, the Company’s outstanding debt consisted of the following:

	March 28, 2021					June 28, 2020
	Amount (in thousands)			Effective Interest Rate		Amount (in thousands)			Effective Interest Rate
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000			2.95	%	800,000			2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000			3.87	%	500,000			3.87	%
Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes")	750,000			3.86	%	750,000			3.86	%
Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes")	1,000,000			4.09	%	1,000,000			4.09	%
Fixed-rate 1.90% Senior Note Due June 15, 2030 ("2030 Notes")	750,000			2.01	%	750,000			2.01	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	17,289		(1)	4.28	%	48,460		(1)	4.28	%
Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes")	750,000			4.93	%	750,000			4.93	%
Fixed-rate 2.875% Senior Note Due June 15, 2050 ("2050 Notes")	750,000			2.93	%	750,000			2.93	%
Fixed-rate 3.125% Senior Note Due June 15, 2060 ("2060 Notes")	500,000			3.18	%	500,000			3.18	%
Total debt outstanding, at par	5,817,289					5,848,460
Unamortized discount	(42,443)					(53,086)
Fair value adjustment - interest rate contracts	7,066		(2)			8,405		(2)
Unamortized bond issuance costs	(7,649)					(8,301)
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478
Reported as:
Current portion of long-term debt	$	813,786				$	836,107
Long-term debt	4,960,477					4,959,371
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478

____________________________

(1) As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Condensed Consolidated Balance Sheets. Additionally, on March 26, 2021, the Company issued a notice of redemption to the existing bondholders, with a redemption date of May 21, 2021.

(2) This amount represents a cumulative fair value gain for discontinued hedging relationships, net of an immaterial amount of amortization as of the periods presented.

Convertible Senior Notes

In June 2012, with the acquisition of Novellus Systems, Inc., the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 15, 2041. The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.

The Company separately accounts for the liability and equity components of the 2041 Notes. The initial debt components of the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table above, respectively. The equity component was initially valued equal to the principal value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.

During the three months ended March 28, 2021, the Company notified holders of the 2041 Notes of its intention to exercise the redemption option pursuant to Section 6.01 of the underlying indenture. As such, the 2041 Notes outstanding on May 21, 2021 will be redeemed by the Company at a price equal to outstanding principal plus accrued and unpaid interest.

20

Under certain circumstances, the 2041 Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of the 2041 Note conversions in the three and nine months ended March 28, 2021, was approximately $9.6 million and $31.2 million, respectively. As a result of the cumulative conversions, as of March 28, 2021, $17.3 million of the 2041 notes remain outstanding.

During the three months ended March 28, 2021 and in the subsequent period through April 28, 2021, the Company received notices of conversion for an immaterial principal value of 2041 Notes, which will settle in the three months ending June 27, 2021.

Selected additional information regarding the 2041 Notes outstanding as of March 28, 2021, and June 28, 2020, is as follows:

	March 28, 2021		June 28, 2020
	2041 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	161,612	$	161,467
Carrying amount of temporary equity component, net of tax	$	3,217	$	10,995
Remaining amortization period (years)	20.1		20.9
Fair Value of Notes (Level 2)	$	319,495
Conversion rate (shares of common stock per $1,000 principal amount of notes)	31.8009
Conversion price (per share of common stock)	$	31.45
If-converted value in excess of par value	$	303,924
Estimated share dilution using average quarterly stock price $538.79 per share	518

Senior Notes

On May 5, 2020, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due June 15, 2030 (the “2030 Notes”), $750 million aggregate principal amount of the Company’s Senior Notes due June 15, 2050 (the “2050 Notes”), and $500 million aggregate principal amount of the Company’s Senior Notes due June 15, 2060 (the “2060 Notes”). The Company pays interest at an annual rate of 1.90%, 2.875%, and 3.125%, on the 2030, 2050, and 2060 Notes, respectively, on a semi-annual basis on June 15 and December 15 of each year.

On March 4, 2019, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2026 (the “2026 Notes”), $1.0 billion aggregate principal amount of the Company’s Senior Notes due March 15, 2029 (the “2029 Notes”), and $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2049 (the “2049 Notes”). The Company pays interest at an annual rate of 3.75%, 4.00%, and 4.875%, on the 2026, 2029, and 2049 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year.

On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2025 (the “2025 Notes”). The Company pays interest at an annual rate of 3.80% on the 2025 Notes on a semi-annual basis on March 15 and September 15 of each year.

On June 7, 2016, the Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year.

The Company may redeem the 2021, 2025, 2026, 2029, 2030, 2049, 2050, and 2060 Notes (collectively the “Senior Notes”) at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the Senior Notes and accrued and unpaid interest before May 15, 2021 for the 2021 Notes, before December 15, 2024 for the 2025 Notes, before January 15, 2026 for the 2026 Notes, before December 15, 2028 for the 2029 Notes, before March 15, 2030 for the 2030 Notes, before September 15, 2048 for the 2049 Notes, before December 15, 2049 for the 2050 Notes, and before December 15, 2059 for the 2060 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021 for the 2021 Notes, on or after December 24, 2024 for the 2025 Notes, on or after January 15, 2026 for the 2026 Notes, on or after December 15, 2028 for the 2029 Notes, on or after March 15, 2030 for the 2030 Notes, on or after September 15, 2048 for the 2049 Notes, on or after December 15, 2049 for the 2050 Notes, and on or after December 15, 2059 for the 2060 Notes. In addition, upon the occurrence of certain events, as

21

described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.

Selected additional information regarding the Senior Notes outstanding as of March 28, 2021, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2021 Notes	0.2	$	802,480
2025 Notes	4.0	$	550,435
2026 Notes	5.0	$	835,095
2029 Notes	8.0	$	1,139,390
2030 Notes	9.2	$	729,968
2049 Notes	28.0	$	973,500
2050 Notes	29.2	$	711,263
2060 Notes	39.2	$	484,215

Revolving Credit Facility

On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), and February 25, 2019 (the “3rd Amendment”). Under the Amended and Restated Credit Agreement (as amended by the 2nd and 3rd Amendment), the Company has a revolving credit facility of $1.25 billion with a syndicate of lenders with an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600.0 million, for a potential total commitment of $1.85 billion. The facility matures on October 13, 2022.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Amended and Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default. As of March 28, 2021, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

Commercial Paper Program

On November 13, 2017, the Company established a commercial paper program (“the CP Program”) under which the Company may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate principal amount of $1.25 billion. The net proceeds from the CP Program will be used for general corporate purposes, including repurchases of the Company’s Common Stock from time to time under the Company’s stock repurchase program. Amounts available under the CP Program may be re-borrowed. The CP Program is backstopped by the Company’s Revolving Credit Arrangement. As of March 28, 2021 and June 28, 2020, the Company had no outstanding borrowings under the CP Program.

22

Interest Cost

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, commercial paper, and the revolving credit facility during the three and nine months ended March 28, 2021 and March 29, 2020.

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Contractual interest coupon	$	49,487	$	40,409	$	148,573	$	122,196
Amortization of interest discount	998		953		3,011		3,346
Amortization of issuance costs	414		408		1,238		1,238
Effect of interest rate contracts, net	516		59		1,533		889
Total interest cost recognized	$	51,415	$	41,829	$	154,355	$	127,669

NOTE 13 — LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company had leases regarding certain improved properties in Fremont and Livermore, California (the “California Facility Leases”) that were classified as operating leases as of June 28, 2020. On September 21, 2020, the Company renewed these leases for an additional seven-year term, and concluded the modified leases are finance leases, and recognized approximately $31.4 million of property and equipment, net, for the associated right of use assets, and $29.8 million of finance lease obligations ($3.1 million classified in current portion of long-term debt and finance lease obligations and the remainder in long-term debt and finance lease obligations, less current portion). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 28, 2021.

During the term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

NOTE 14 — COMMITMENTS AND CONTINGENCIES

Refer to Note 13 - Leases for details regarding guarantees surrounding selected leases.

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of March 28, 2021, the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

23

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of March 28, 2021, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $73.2 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid.

In addition, the Company has entered into indemnification agreements with its officers and directors, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. As of March 28, 2021, warranty reserves totaling $16.4 million were recognized in other long-term liabilities, the remainder were included in accrued expenses and other current liabilities in the Company’s Condensed Consolidated Balance Sheets.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Balance at beginning of period	$	153,214	$	118,193	$	129,197	$	127,932
Warranties issued during the period	60,223		44,898		163,869		115,798
Settlements made during the period	(45,792)		(31,647)		(123,462)		(98,563)
Changes in liability for pre-existing warranties	4,801		(1,252)		2,842		(14,975)
Balance at end of period	$	172,446	$	130,192	$	172,446	$	130,192

Legal Proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.

NOTE 15 — STOCK REPURCHASE PROGRAM

In November 2020, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

24

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 28, 2020						$	1,773,427
Quarter ended September 27, 2020	1,344	$	461,998	$	343.73	$	1,311,429
Board authorization, $5 billion increase, November 2020						$	6,311,429
Quarter ended December 27, 2020	1,789	$	724,485	$	404.98	$	5,586,944
Quarter ended March 28, 2021	1,474	$	925,099	$	519.30	$	4,661,845

(1) Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 28, 2021.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and nine months ended March 28, 2021, the Company acquired 257 thousand shares at a total cost of $152.3 million and 280 thousand shares at a total cost of $160.6 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

Accelerated Share Repurchase Agreements

On February 11, 2021, the Company entered into an accelerated share repurchase agreement (the “February 2021 ASR") with a financial institution to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 655 thousand shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on February 11, 2021. The total number of shares received under the February 2021 ASR will be based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the February 2021 ASR will occur no later than June 9, 2021.

NOTE 16 — ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive loss, net of tax at March 28, 2021, as well as the activity for the nine months ending March 28, 2021, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges			Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments			Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 28, 2020	$	(45,811)	$	(32,796)		$	4,923		$	(20,527)	$	(94,211)
Other comprehensive income (loss) before reclassifications	20,231		12,546			(3,667)			234		29,344
Losses reclassified from accumulated other comprehensive loss to net income	—		843		(1)	727		(2)	—		1,570
Net current-period other comprehensive income (loss)	20,231		13,389			(2,940)			234		30,914
Balance at March 28, 2021	$	(25,580)	$	(19,407)		$	1,983		$	(20,293)	$	(63,297)

(1) Amount of after-tax loss reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

(2) Amount of after-tax loss reclassified from accumulated other comprehensive income into net income located in other expense, net.

25

ITEM 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified as forward-looking, by use of phrases and words such as “believe,” “estimated,” “anticipate,” “expect,” “probable,” “intend,” “plan,” “aim,” “may,” “should,” “could,” “would,” “will,” “continue,” and other future-oriented terms. The identification of certain statements as “forward-looking” does not mean that other statements not specifically identified are not forward-looking. Forward-looking statements include but are not limited to statements that relate to: trends and opportunities in the global economic environment and the semiconductor industry; the anticipated levels of, and rates of change in, margins, market share, served addressable market, capital expenditures, research and development expenditures, international sales, revenue (actual and/or deferred), operating expenses and earnings generally; management’s plans and objectives for our current and future operations and business focus; volatility in our quarterly results; customer and end user requirements and our ability to satisfy those requirements; customer capital spending and their demand for our products and services, and the reliability of indicators of change in customer spending and demand; the effect of variability in our customers’ business plans or demand for our equipment and services; changes in demand for our products and in our market share resulting from, among other things, any changes in our customers’ proportion of capital expenditure (with respect to certain technology inflections); hedging transactions; debt or financing arrangements; our competition, and our ability to defend our market share and to gain new market share; our ability to obtain and qualify alternative sources of supply; changes in state, federal and international tax laws, our estimated annual tax rate and the factors that affect our tax rates; anticipated growth or decline in the industry and the total market for wafer fabrication equipment, our growth relative thereto and the resulting impact on us from such growth or decline; the success of joint development and collaboration relationships with customers, suppliers, or others; outsourced activities; the role of component suppliers in our business; our leadership and competency, and our ability to facilitate innovation; our ability to continue to, including the underlying factors that, create sustainable differentiation; the resources invested to comply with evolving standards and the impact of such efforts; legal and regulatory compliance; the estimates we make, and the accruals we record, in order to implement our critical accounting policies (including but not limited to the adequacy of prior tax payments, future tax benefits or liabilities, and the adequacy of our accruals relating to them); our investment portfolio; our access to capital markets; uses of, payments of, and impact of interest rate fluctuations on, our debt; our intention to pay quarterly dividends and the amounts thereof, if any; our ability and intention to repurchase our shares; credit risks; controls and procedures; recognition or amortization of expenses; our ability to manage and grow our cash position; our strategic relevance with our customers; our ability to scale our operations to respond to changes in our business; the value of our patents; the materiality of potential losses arising from legal proceedings; the probability of making payments under our guarantees; the impact of the COVID-19 pandemic, and the sufficiency of our financial resources or liquidity to support future business activities (including but not limited to operations, investments, debt service requirements, dividends, and capital expenditures). Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value, and effect, including without limitation those discussed below under the heading “Risk Factors” within Part II Item 1A and elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (“SEC”), such as our annual report on Form 10-K for the year ended June 28, 2020 (our “2020 Form 10-K”), our quarterly reports on Form 10-Q for the fiscal quarters ended September 27, 2020 and December 27, 2020, and our current reports on Form 8-K. Such risks, uncertainties, and changes in condition, significance, value, and effect could cause our actual results to differ materially from those expressed in this report and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We do not undertake any obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.

Documents To Review In Connection With Management’s Discussion and Analysis Of Financial Condition and Results Of Operations

For a full understanding of our financial position and results of operations for the three and nine months ended March 28, 2021, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations below, you should also read the Condensed Consolidated Financial Statements and notes presented in this Form 10-Q and the financial statements and notes in our 2020 Form 10-K.

26

EXECUTIVE SUMMARY

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong global presence with core competencies in areas like nanoscale applications enablement, chemistry, plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are designed to help our customers build smaller, faster, and better performing devices that are used in a variety of electronic products, including mobile phones, personal computers, servers, wearables, automotive vehicles, and data storage devices.

Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such as non-volatile memory, dynamic random-access memory, and logic devices. We aim to increase our strategic relevance with our customers by contributing more to their continued success. Our core technical competency is integrating hardware, process, materials, software, and process control, enabling results on the wafer.

Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-effective.

Demand from the Cloud, Internet of Things, and other markets is driving the need for increasingly powerful and cost-efficient semiconductors. At the same time, there are growing technical challenges with traditional scaling. These trends are driving significant inflections in semiconductor manufacturing, such as the increasing importance of vertical 3D scaling strategies as well as multiple patterning to enable shrinks.

We believe we are in a strong position with our leadership and competency in deposition, etch, and clean to facilitate some of the most significant innovations in semiconductor device manufacturing. We have a broad portfolio of products that provide complementary processing steps used throughout semiconductor manufacturing. Our Customer Support Business Group focuses attention on delivering solutions that meet our customers’ technical requirements and productivity needs during the equipment lifecycle. Several factors create opportunity for sustainable differentiation for us: (i) our focus on research and development, with several on-going programs relating to sustaining engineering, product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles of learning from our broad installed base; (iii) our collaborative focus with ecosystem partners; and (iv) our focus on delivering our multi-product solutions with a goal to enhance the value of Lam’s solutions to our customers.

In calendar year 2020, there was an increase in wafer fabrication equipment spending by semiconductor manufacturers, driven by the robust secular demand for semiconductors in a number of markets including high-performance computing, personal computers, and 5G networks. During the March 2021 quarter, customer demand was strong, and we continued to increase our production output levels as we operated under COVID-19-related safety protocols. While we are currently seeing improvements in both our own operations and those of our suppliers, we have experienced higher costs of goods sold related to freight and logistics. Risks and uncertainties related to the COVID-19 pandemic remain, which may continue to negatively impact our revenue and gross margin. Over the longer term, we believe that secular demand for semiconductors will continue to drive sustainable growth for our products and services, and that technology inflections in our industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, will lead to an increase in the served addressable market for our products and services in the deposition, etch, and clean businesses.

The following table summarizes certain key financial information for the periods indicated below:

	Three Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020
	(in thousands, except per share data and percentages)
Revenue	$	3,847,654		$	3,456,237		$	2,503,625
Gross margin	$	1,780,131		$	1,603,795		$	1,167,007
Gross margin as a percent of total revenue	46.3		%	46.4		%	46.6		%
Total operating expenses	$	584,823		$	594,071		$	472,893
Net income	$	1,071,121		$	869,229		$	574,781
Diluted net income per share	$	7.41		$	5.96		$	3.88

27

In the March 2021 quarter, revenue increased 11% compared to the December 2020 quarter, with increases in both systems and customer support-related revenue, reflective of a strong wafer fabrication equipment environment. The decrease in gross margin as a percentage of revenue in the March 2021 quarter compared to the December 2020 quarter was primarily driven by higher levels of manufacturing-related spending and higher employee-related costs, partially offset by favorable changes in customer and product mix. The decrease in operating expenses in the March 2021 quarter compared to the December 2020 quarter was mainly driven by decreases in outside services and deferred compensation plan-related costs, partially offset by increases in employee-related costs from seasonality and increased headcount.

Our cash and cash equivalents, investments, and restricted cash and investments balances decreased to $6.0 billion at the end of the March 2021 quarter compared to $6.3 billion at the end of the December 2020 quarter. This decrease was primarily the result of $1.1 billion of share repurchases, including net share settlement on employee stock-based compensation; $186.6 million of dividends paid to stockholders; and $89.6 million of capital expenditures, partially offset by $1.2 billion of cash generated from operating activities. Employee headcount as of March 28, 2021 was approximately 13,100.

RESULTS OF OPERATIONS

Revenue

	Three Months Ended									Nine Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020			March 28, 2021			March 29, 2020
Revenue (in millions)	$	3,848		$	3,456		$	2,504		$	10,481		$	7,253
China	32		%	35		%	32		%	34		%	29		%
Korea	31		%	21		%	23		%	25		%	21		%
Taiwan	14		%	17		%	21		%	15		%	22		%
Japan	7		%	10		%	10		%	10		%	10		%
Southeast Asia	7		%	10		%	2		%	8		%	6		%
United States	5		%	4		%	9		%	5		%	9		%
Europe	4		%	3		%	3		%	3		%	3		%

Revenue for the March 2021 quarter increased 11% from the December 2020 quarter, reflecting increased customer spending on capital equipment and services.

The following table presents our revenue disaggregated between system and customer support-related revenue:

	Three Months Ended						Nine Months Ended
	March 28, 2021		December 27, 2020		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
System revenue	$	2,545,306	$	2,307,421	$	1,647,560	$	7,000,968	$	4,759,881
Customer support-related revenue and other	1,302,348		1,148,816		856,065		3,480,003		2,492,991
	$	3,847,654	$	3,456,237	$	2,503,625	$	10,480,971	$	7,252,872

Please refer to Note 3, “Revenue,” to the Condensed Consolidated Financial Statements of this Form 10-Q for additional information regarding the composition of the two categories into which revenue has been disaggregated.

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets we serve:

	Three Months Ended						Nine Months Ended
	March 28, 2021		December 27, 2020		March 29, 2020		March 28, 2021		March 29, 2020
Memory	62	%	68	%	56	%	62	%	57	%
Foundry	31	%	26	%	31	%	31	%	31	%
Logic/integrated device manufacturing	7	%	6	%	13	%	7	%	12	%

28

Gross Margin

	Three Months Ended									Nine Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Gross margin	$	1,780,131		$	1,603,795		$	1,167,007		$	4,890,105		$	3,328,361
Percent of revenue	46.3		%	46.4		%	46.6		%	46.7		%	45.9		%

Gross margin as a percentage of revenue was lower in the March 2021 quarter compared to the December 2020 quarter primarily as a result of higher manufacturing-related spending and higher employee-related costs, partially offset by favorable changes in customer and product mix.

The decrease in gross margin as a percentage of revenue in the March 2021 quarter compared to the same period in the prior year was primarily driven by increased manufacturing-related spending as a result of COVID-19 disruptions, deferred compensation plan-related costs and employee-related expenses, partially offset by favorable changes in customer and product mix.

The increase in gross margin as a percentage of revenue in the nine months ended March 28, 2021 compared to the same period in the prior year was primarily driven by favorable changes in customer and product mix, partially offset by increases in manufacturing-related spending as a result of COVID-19 disruptions, deferred compensation plan-related costs and employee-related expenses.

Research and Development

	Three Months Ended									Nine Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Research & development (“R&D”)	$	381,120		$	375,172		$	307,914		$	1,111,659		$	913,602
Percent of revenue	9.9		%	10.9		%	12.3		%	10.6		%	12.6		%

We continued to make significant R&D investments in the March 2021 quarter focused on leading-edge deposition, etch, clean and other semiconductor manufacturing processes. The increase in R&D expense in the March 2021 quarter compared to the December 2020 quarter was primarily driven by an increase of $22 million in employee-related expenses from increased headcount and seasonality, partially offset by decreases of $11 million in outside services and $7 million in deferred compensation plan-related costs.

The increase in R&D expense in the March 2021 quarter compared to the same period in the prior year was primarily driven by increases of $39 million in employee-related expenses as a result of increased headcount, $19 million in deferred compensation plan-related costs and $9 million in outside services.

The increase in R&D expense in the nine months ended March 28, 2021 compared to the same period in the prior year was primarily driven by increases of $105 million in employee-related expenses as a result of increased headcount, $39 million in outside services, $30 million in deferred compensation plan-related costs, and $27 million in spending for supplies.

Selling, General, and Administrative

	Three Months Ended									Nine Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Selling, general, and administrative (“SG&A”)	$	203,703		$	218,899		$	164,979		$	612,350		$	496,679
Percent of revenue	5.3		%	6.3		%	6.6		%	5.8		%	6.8		%

SG&A expense during the March 2021 quarter decreased in comparison to the December 2020 quarter, primarily due to decreases of $5 million in deferred compensation plan-related costs and $4 million in outside services.

29

SG&A expense during the March 2021 quarter increased compared to the same period in the prior year, primarily driven by increases of $29 million in employee-related expenses from increased headcount and $13 million in deferred compensation plan-related costs.

The increase in SG&A expense in the nine months ended March 28, 2021 compared to the same period in the prior year was primarily due to increases of $72 million in employee-related expenses from increased headcount, $24 million in outside services, and $20 million in deferred compensation plan-related costs.

Other Expense, Net

Other expense, net consisted of the following:

	Three Months Ended						Nine Months Ended
	March 28, 2021		December 27, 2020		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Interest income	$	4,209	$	4,796	$	18,856	$	15,964	$	76,094
Interest expense	(52,236)		(52,551)		(41,580)		(156,902)		(128,190)
Gains (losses) on deferred compensation plan-related assets, net	7,520		24,207		(33,828)		44,654		(20,135)
Foreign exchange gains (losses), net	541		(3,763)		480		(4,597)		(2,336)
Other, net	4,646		(2,630)		(8,547)		(3,172)		(16,704)
	$	(35,320)	$	(29,941)	$	(64,619)	$	(104,053)	$	(91,271)

Interest income decreased in the March 2021 quarter compared to the December 2020 quarter as a result of a lower cash balance and lower yield. The decrease in interest income in the March 2021 quarter and in the nine months ended March 28, 2021 compared to the same periods in the prior year was as a result of lower yield.

Interest expense remained relatively flat in the March 2021 quarter compared to the December 2020 quarter as there was no significant debt activity. Interest expense increased in the March 2021 quarter and in the nine months ended March 28, 2021 compared to the same periods in the prior year due to the May 2020 issuance of the $2.0 billion senior notes, partially offset by the retirement of $500 million of senior notes in March 2020 and conversions of the 2041 Notes.

The gains and losses on deferred compensation plan-related assets in the March 2021, December 2020, and March 2020 quarters were driven by fluctuations in the fair market value of the underlying funds.

Foreign exchange fluctuations were primarily due to currency movements against portions of our unhedged balance sheet exposures.

Other, net generated income during the March 2021 quarter compared to expenses during the December 2020 and March 2020 quarters in part due to gains from our private equity investments.

Income Tax Expense

Our provision for income taxes and effective tax rate for the periods indicated were as follows:

	Three Months Ended									Nine Months Ended
	March 28, 2021			December 27, 2020			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Income tax expense	$	88,867		$	110,554		$	54,714		$	298,242		$	271,729
Effective tax rate	7.7		%	11.3		%	8.7		%	9.7		%	14.9		%

The decrease in the effective tax rate for the March 2021 quarter compared to the December 2020 quarter was primarily due to stock-based compensation excess tax benefits and the change in level and proportion of income in higher and lower tax jurisdictions.

The decrease in the effective tax rate for the three and nine months ended March 28, 2021 compared to the same periods in the prior year was primarily due to stock-based compensation excess tax benefits in the three months ended March 2021 and a cumulative income tax benefit reversal due to a court ruling in the nine months ended March 2020, respectively.

30

International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States. International pre-tax income is taxable in the United States at a lower effective tax rate than the federal statutory tax rate. Please refer to Note 7, “Income Taxes,” to our Consolidated Financial Statements in Part II, Item 8 of our 2020 Form 10-K for additional information.

We re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Any change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

A critical accounting policy is defined as one that has both a material impact on our financial condition and results of operations and requires us to make difficult, complex and/or subjective judgments, often as a result of the need to make estimates about matters that are inherently uncertain. The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make certain judgments, estimates and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates and assumptions on historical experience and on various other assumptions we believe to be applicable and evaluate them on an ongoing basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates, which could have a material impact on our business, results of operations, and financial condition. Our critical accounting estimates include:

•the recognition and valuation of revenue from arrangements with multiple performance obligations which impacts revenue;

•the valuation of inventory, which impacts gross margin;

•the valuation of warranty reserves, which impacts gross margin;

•the recognition and measurement of current and deferred income taxes, including the measurement of uncertain tax positions, which impact our provision for income tax expenses; and

•the valuation and recoverability of long-lived assets, which impacts gross margin and operating expenses when we record asset impairments or accelerate their depreciation or amortization.

We believe that the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of our condensed consolidated financial statements regarding the critical accounting estimates indicated above.

Revenue Recognition: We recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services by following a five-step process, (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when or as we satisfy a performance obligation, as further described below.

Identify the contract with a customer. We generally consider documentation of terms with an approved purchase order as a customer contract, provided that collection is considered probable, which is assessed based on the creditworthiness of the customer as determined by credit checks, payment histories, and/or other circumstances.

Identify the performance obligations in the contract. Performance obligations include sales of systems, spare parts, and services. In addition, our customer contracts contain provisions for installation and training services which have been deemed immaterial in the context of the contract.

Determine the transaction price. The transaction price for our contracts with customers consists of both fixed and variable consideration provided it is probable that a significant reversal of revenue will not occur when the uncertainty related to variable consideration is resolved. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes estimates for discounts and credits for future usage which are based on contractual terms outlined in volume purchase agreements and other factors known at the time. We generally invoice customers at shipment and for professional services either as provided or upon meeting certain milestones. Customer invoices are generally due within 30 to 90 days after issuance. Our contracts with customers typically do not include significant financing components as the period between the transfer of performance obligations and timing of payment are generally within one year.

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, we allocate the transaction price to the performance obligations in the contract on a relative standalone selling price

31

basis. Standalone selling prices are based on multiple factors including, but not limited to historical discounting trends for products and services and pricing practices in different geographies.

Recognize revenue when or as we satisfy a performance obligation. Revenue for systems and spares are recognized at a point in time, which is generally upon shipment or delivery. Revenue from services is recognized over time as services are completed or ratably over the contractual period of generally one year or less.

Inventory Valuation: Our policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. Estimates of market value include but are not limited to management’s forecasts related to our future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than our projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which we make the revision.

Warranty: We record a provision for estimated warranty expenses to cost of sales for each system when we recognize revenue. We periodically monitor the performance and cost of warranty activities, if actual costs incurred are different than our estimates, we may recognize adjustments to provisions in the period in which those differences arise or are identified. We do not maintain general or unspecified reserves; all warranty reserves are related to specific systems.

Income Taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at this time. In the event that we determine that we will not be able to realize all or part of our net deferred tax assets, an adjustment will be charged to earnings in the period such determination is made. Likewise, if we later determine that it is more likely than not that the deferred tax assets will be realized, then the previously provided valuation allowance will be reversed.

We recognize the benefit from a tax position only if it is more likely than not that the position will be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to uncertain tax positions as a component of income tax expense.

Long-lived Assets: We review goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, we will perform an impairment test at that date. In testing for a potential impairment of goodwill, we: (1) allocate goodwill to the reporting units to which the acquired goodwill relates; (2) estimate the fair value of our reporting units; and (3) determine the carrying value (book value) of those reporting units. Prior to this allocation of the assets to the reporting units, we assess long-lived assets for impairment. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, we must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In our goodwill impairment process we first assess qualitative factors to determine whether it is necessary to perform a quantitative analysis. We do not calculate the fair value of a reporting unit unless we determine, based on a qualitative assessment, that it is more likely than not that the reporting unit’s fair value is less than its carrying amount.

The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. We determine the fair value of our reporting units by using an income approach. Under the income approach, we determine fair value based on estimated future cash flows of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn.

In estimating the fair value of a reporting unit, we make estimates and judgments about the future cash flows of our reporting units, including estimated growth rates and assumptions about the economic environment. Although our cash flow forecasts are based on assumptions that are consistent with the plans and estimates we are using to manage the underlying businesses, there is significant judgment involved in determining the cash flows attributable to a reporting unit. In addition, we make certain judgments about allocating shared assets to the estimated balance sheets of our reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge.

32

As a result, several factors could result in an impairment of a material amount of our goodwill balance in future periods, including but not limited to: (1) weakening of the global economy, weakness in the semiconductor equipment industry, or our failure to reach internal forecasts, which could impact our ability to achieve our forecasted levels of cash flows and reduce the estimated discounted cash flow value of our reporting units; and (2) a decline in our Common Stock price and resulting market capitalization, to the extent we determine that the decline is sustained and indicates a reduction in the fair value of our reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and lifecycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, we may be required to record an impairment charge to write down the asset to its realizable value.

For other long-lived assets, we routinely consider whether indicators of impairment are present. If such indicators are present, we determine whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, we recognize an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. We recognize an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The fair value of the asset then becomes the asset’s new carrying value, which we depreciate over the remaining estimated useful life of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value. In addition, for fully amortized intangible assets, we de-recognize the gross cost and accumulated amortization in the period we determine the intangible asset no longer enhances future cash flows.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our Condensed Consolidated Financial Statements, see Note 2 - Recent Accounting Pronouncements, of our Condensed Consolidated Financial Statements, included in Part 1 of this Form 10-Q.

LIQUIDITY AND CAPITAL RESOURCES

Total gross cash, cash equivalents, investments, and restricted cash and investments balances were $6.0 billion at March 28, 2021 compared to $7.0 billion as of June 28, 2020. This decrease was primarily driven by $2.3 billion of share repurchases, including net share settlement on employee stock-based compensation, $541.6 million in dividends paid, and $244.5 million of capital expenditures, partially offset by $2.2 billion of cash generated from operating activities.

Cash Flow from Operating Activities

Net cash provided by operating activities of $2.2 billion during the nine months ended March 28, 2021, consisted of (in thousands):

Net income	$	2,763,801
Non-cash charges:
Depreciation and amortization	228,754
Equity-based compensation expense	163,843
Deferred income taxes	(5,448)
Amortization of note discounts and issuance costs	4,251
Changes in operating asset and liability accounts	(1,009,116)
Other	6,143
	$	2,152,228

Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in accounts receivable of $710.0 million, inventory of $634.9 million, and prepaid expense and other assets of $41.4 million, along with a decrease in accrued expenses and other liabilities of $0.8 million. The uses of cash are offset by the following sources of cash: increases in trade accounts payable of $103.5 million and deferred profit of $274.5 million.

Cash Flow from Investing Activities

Net cash used for investing activities during the nine months ended March 28, 2021, was $615.8 million, primarily consisting of net purchases of available-for-sale securities of $335.4 million along with capital expenditures of $244.5 million.

33

Cash Flow from Financing Activities

Net cash used for financing activities during the nine months ended March 28, 2021, was $2.8 billion, primarily consisting of $2.3 billion in treasury stock repurchases, including net share settlement on employee stock-based compensation, $541.6 million in dividends paid, and $40.0 million of cash paid for debt repayment, partially offset by $64.7 million combined proceeds from issuance of common stock and reissuance of treasury stock.

Liquidity

Given that the semiconductor industry is highly competitive and has historically experienced rapid changes in demand, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Anticipated cash flows from operations based on our current business outlook, combined with our current levels of cash, cash equivalents, and short-term investments as of March 28, 2021, are expected to be sufficient to support our anticipated levels of operations, investments, debt service requirements, capital expenditures, capital redistributions, and dividends through at least the next twelve months. However, uncertainty in the global economy and the semiconductor industry, as well as disruptions in credit markets, have in the past, and could in the future, impact customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers, and creditors.

Under certain circumstances, our 2041 Notes may be converted and settled in cash and shares of our Common Stock. During the nine months ended March 28, 2021, approximately $31.2 million principal value of convertible 2041 Notes were converted and in the subsequent period through April 28, 2021, we received notices of conversion of an immaterial principal value of 2041 Notes, which will settle in the three months ending June 27, 2021. During the three months ended March 28, 2021, we notified holders of the 2041 Notes of our intention to exercise the redemption option pursuant to Section 6.01 of the underlying indenture. As such, the 2041 Notes outstanding on May 21, 2021 will be redeemed at a price equal to outstanding principal plus accrued and unpaid interest. We expect to have sufficient levels of cash, cash equivalents, and short-term investments to fund the settlement of the 2041 Notes.

In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, the disruption in the capital markets caused by the COVID-19 pandemic could make any financing more challenging, and there can be no assurance that we will be able to obtain such financing on commercially reasonable terms or at all.

ITEM 3.    Quantitative and Qualitative Disclosures about Market Risk

For financial market risks related to changes in interest rates, marketable equity security prices, and foreign currency exchange rates, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in our 2020 Form 10-K. Other than as noted below, our exposure related to market risk has not changed materially since June 28, 2020. All of the potential changes noted below are based on sensitivity analysis performed on our financial position as of March 28, 2021. Actual results may differ materially.

Fixed Income Securities

Our investments in various interest earning securities carry a degree of market risk for changes in interest rates. At any time, a sharp rise in interest rates could have a material adverse impact on the fair value of our fixed income investment portfolio. Conversely, declines in interest rates could have a material adverse impact on interest income for our investment portfolio. We target to maintain a conservative investment policy, which focuses on the safety and preservation of our capital by limiting default risk, market risk, reinvestment risk, and concentration risk.

34

The following table presents the hypothetical fair values of fixed income securities that would result from selected potential decreases and increases in interest rates. Market changes reflect immediate hypothetical parallel shifts in the yield curve of plus or minus 50 basis points (“BPS”), 100 BPS, and 150 BPS with a minimum interest rate of zero BPS. The hypothetical fair values as of March 28, 2021, were as follows:

	Valuation of Securities Given an Interest Rate Decrease of X Basis Points						Fair Value  as of March 28, 2021		Valuation of Securities Given an Interest Rate Increase of X Basis Points
	(150 BPS)		(100 BPS)		(50 BPS)		0.00%		50 BPS		100 BPS		150 BPS
	(in thousands)
U.S. Treasury and agencies	$	385,805	$	385,805	$	385,776	$	385,657	$	384,930	$	384,202	$	383,474
Government-sponsored enterprises	3,523		3,523		3,523		3,512		3,480		3,448		3,415
Foreign government bonds	47,226		47,226		47,226		47,141		46,994		46,847		46,700
Corporate notes and bonds	1,852,479		1,852,431		1,851,795		1,846,311		1,839,354		1,832,397		1,825,440
Mortgage backed securities - residential	6,446		6,419		6,393		6,353		6,293		6,233		6,172
Mortgage backed securities - commercial	12,385		12,380		12,365		12,266		12,163		12,062		11,960
Total	$	2,307,864	$	2,307,784	$	2,307,078	$	2,301,240	$	2,293,214	$	2,285,189	$	2,277,161

We mitigate default risk by investing in high credit quality securities and by positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to achieve portfolio liquidity and maintain a prudent amount of diversification.

ITEM 4.    Controls and Procedures

Design of Disclosure Controls and Procedures and Internal Control over Financial Reporting

We maintain disclosure controls and procedures and internal control over final reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.

Disclosure Controls and Procedures

As required by Exchange Act Rule 13a-15(b), as of March 28, 2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer, along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Effectiveness of Controls

While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting.

35

PART II.    OTHER INFORMATION

ITEM 1.    Legal Proceedings

Please refer to the subsection entitled “Legal Proceedings” within Note 14 “Commitments and Contingencies,” to our Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.

ITEM 1A.    Risk Factors

In addition to the other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating us and our business because such factors may significantly impact our business, operating results, and financial condition. Many of the following risk factors have been, and could be further, exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended by, nor should be attached to, the order in which the risk factors appear.

INDUSTRY AND CUSTOMER RISKS

The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions

The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. The industry environment has moved toward being more characterized by variability across segments and customers, accentuated by consolidation within the industry. Variability in our customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results. The variability in our customers’ investments during any particular period is dependent on several factors, including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending and other resources allocated to operating activities.

During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems, and procedures for training, assimilating, and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or declining demand, our gross margins and earnings may be negatively impacted. For example, the COVID-19 outbreak has impacted and could further impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or "stay at home" orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the outbreak.

We continuously reassess our strategic resource allocation choices in response to the changing business environment. If we do not adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we may expand our capacity and resources too rapidly and/or beyond what is appropriate for the actual demand environment, resulting in excess fixed costs.

Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively.

36

Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial Condition

Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor capital equipment market may experience rapid changes in demand driven both by changes in the market generally and the plans and requirements of particular customers. The economic, political, and business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically impacted customer demand for our products and normal commercial relationships with our customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and services. As a result, changing economic, political or business conditions can cause material adverse changes to our results of operations and financial condition, including but not limited to: 

•a decline in demand for our products or services;

•an increase in reserves on accounts receivable due to our customers’ inability to pay us;

•an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such inventory;

•valuation allowances on deferred tax assets;

•restructuring charges;

•asset impairments including the potential impairment of goodwill and other intangible assets;

•a decline in the value of our investments;

•exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that do not come to fruition;

•a decline in the value of certain facilities we lease to less than our residual value guarantee with the lessor; and

•challenges maintaining reliable and uninterrupted sources of supply.

Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, operating results, and earnings. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our profitability and other financial results.

We Have a Limited Number of Key Customers

Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. As a result, the actions of even one customer may subject us to variability in those areas that is difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us; compliance with specific environmental, social, and corporate governance standards; and limitations on our ability to share technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.

We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our Success; Consequently, We Are Subject to Risks Associated with Rapid Technological Change

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products or existing products have reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture products successfully, or products that we introduce may fail in the marketplace. For more than 25 years, the primary driver of technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate more complex changes in multiple technologies in an effort to continue technology development. In addition, the emergence of “big data” and new tools such as machine learning and artificial intelligence that capitalize on the availability of large data sets is leading semiconductor manufacturers and equipment manufacturers to pursue new products and approaches that exploit those tools to advance technology development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on developing the technology changes that are ultimately successful in supporting our customer requirements. Our failure to develop and offer the

37

correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share, unanticipated costs, and inventory obsolescence, which would adversely affect our financial results.

In order to develop new products and processes and enhance existing products and processes, we expect to continue to make significant investments in R&D, to investigate the acquisition of new products and technologies, to invest in or acquire such business or technologies, and to pursue joint development relationships with customers, suppliers, or other members of the industry. Our investments and acquisitions may not be as successful as we may expect, particularly in the event that we invest in or acquire product lines and technologies that are new to us. We may find that acquisitions are not available to us, for regulatory or other reasons, and that we must therefore limit ourselves to collaboration and joint venture development activities, which do not have the same benefits as acquisitions. Pursuing development through collaboration and/or joint development activities rather than through an acquisition poses substantial challenges for management, including those related to aligning business objectives; sharing confidential information, intellectual property and data; sharing value with third parties; and realizing synergies that might have been available in an acquisition but are not available through a joint development project. We must manage product transitions and joint development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and certain jointly developed technologies may be subject to restrictions on our ability to share that technology with other customers, which could limit our market for products incorporating those technologies. Future technologies, processes, or product developments may render our current product offerings obsolete, leaving us with non-competitive products, obsolete inventory, or both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next-generation devices. This shift may result in a reduction in the size of our addressable markets or could increase the relative size of markets in which we either do not compete or have relatively low market share.

Strategic Alliances and Customer Consolidation May Have Negative Effects on Our Business

Increasingly, semiconductor manufacturing companies are entering into strategic alliances or consolidating with one another to expedite the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that use a specific set of manufacturing equipment, while the outcomes of consolidation can lead to an overall reduction in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include our customers re-evaluating their future supplier relationships to consider our competitors’ products and/or gaining additional influence over the pricing of products and the control of intellectual property or data.

Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even if they select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights, that increase our costs or require us to take on greater risk. These actions could adversely impact our market share and financial results.

Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase That Competitor’s Equipment, Making It More Difficult for Us to Sell Our Equipment to That Customer

Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially for customers that are more focused on tool reuse. Accordingly, we expect it to be more difficult to sell our products to a given customer for a product line application if that customer initially selects a competitor’s equipment for the same product line application.

38

We Face a Challenging and Complex Competitive Environment

We face significant competition from multiple competitors, and with increased consolidation efforts in our industry, as well as the emergence and strengthening of new, regional competitors, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire businesses and products that are competitive to ours and may introduce new products and product capabilities that may affect our ability to sell and support our existing products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.

We believe that to remain competitive we must devote significant financial resources to offer products that meet our customers’ needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Technological changes and developing technologies, have required, and are expected to continue to require, new and costly investments. Certain of our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to offer customers a more comprehensive array of products and/or product capabilities and to therefore achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. We also face competition from our own customers, who in some instances have established affiliated entities that manufacture equipment similar to ours. In addition, we face competition from companies that exist in a more favorable legal or regulatory environment than we do, allowing the freedom of action in ways that we may be unable to match. In many cases speed to solution is necessary for customer satisfaction and our competitors may be better positioned to achieve these objectives. For these reasons, we may fail to continue to compete successfully worldwide.

In addition, our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be unable to continue to compete successfully in our markets, which could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.

BUSINESS AND OPERATIONAL RISKS

The COVID-19 Outbreak Has Adversely Impacted, and May Continue to Adversely Impact, Our Business, Operations, and Financial Results

The COVID-19 outbreak and efforts by national, state and local governments worldwide to control its spread have resulted in widespread measures aimed at containing the disease such as quarantines, travel bans, shutdowns, and shelter in place or “stay at home” orders, which collectively have significantly restricted the movement of people and goods and the ability of businesses to operate. These restrictions and measures, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and our efforts to act in the best interests of our employees, customers, and suppliers, have affected and are affecting our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that require changes to existing manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by a large proportion of our workforce. These impacts have caused and are expected to continue to cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which have caused and are expected to cause an adverse effect on our results of operations that may be material. The potential duration and impact of the outbreak on the global economy and on our business are difficult to predict and cannot be estimated with any degree of certainty, but the outbreak has resulted in significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty, which has adversely impacted our business and may continue to do so, and may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.

39

Our Revenues and Operating Results Are Variable

Our revenues and operating results may fluctuate significantly from quarter to quarter or year to year due to a number of factors, not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. Because our operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of gross profit from a small number of transactions can unfavorably affect operating results in a particular quarter or year. Factors that may cause our financial results to fluctuate unpredictably include but are not limited to:

•economic conditions in the electronics and semiconductor industries in general and specifically the semiconductor equipment industry;

•the size and timing of orders from customers;

•consolidation of the customer base, which may result in the investment decisions of one customer or market having a significant effect on demand for our products or services;

•procurement shortages;

•the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our expectations;

•manufacturing difficulties;

•customer cancellations or delays in shipments, installations, customer payments, and/or customer acceptances;

•the extent that customers continue to purchase and use our products and services in their business;

•our customers’ reuse of existing and installed products, to the extent that such reuse decreases their need to purchase new products or services;

•changes in average selling prices, customer mix, and product mix;

•our ability to develop, introduce, and market new, enhanced, and competitive products in a timely manner;

•our competitors’ introduction of new products;

•legal or technical challenges to our products and technologies;

•transportation, communication, demand, information technology, or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, widespread outbreak of illness, natural or man-made disasters, or climate change;

•legal, tax, accounting, or regulatory changes (including but not limited to changes in import/export regulations and tariffs) or changes in the interpretation or enforcement of existing requirements;

•changes in our estimated effective tax rate; and

•foreign currency exchange rate fluctuations.

For example, the COVID–19 outbreak has impacted and could further impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or "stay at home" orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the outbreak.

Certain Critical Information Systems, That We Rely on for the Operation of Our Business and Products That We Sell, Are Susceptible to Cybersecurity and Other Threats or Incidents

We maintain and rely upon certain critical information systems for the effective operation of our business. These information systems include but are not limited to, telecommunications, the Internet, our corporate intranet, various computer hardware and software applications, (some of which may be integrated into the products that we sell or be required in order to provide the services that we offer), network communications, and email. These information systems may be owned and maintained by us, our outsourced providers, or third parties such as vendors, contractors, customers and Cloud providers. In addition, we make use of Software-As-A-Service (SAAS) products for certain important business functions that are provided by third parties and hosted on their own networks and servers, or third-party networks and servers, all of which rely on networks, email and/or the Internet for their function. All of these information systems are subject to disruption, breach or failure from various sources, including those using techniques that change frequently or may be disguised or difficult to detect, or designed to remain dormant until a triggering event, or that may continue undetected for an extended period of time. Those sources may include mistakes or unauthorized actions by our employees or contractors, phishing schemes and other third-party attacks, and degradation or loss of service or access to data due to viruses, malware, denial of service attacks, destructive or inadequate code, power failures, or physical damage to computers, hard drives, communication lines, or networking equipment.

We have experienced cybersecurity and other threats and incidents in the past. Although past threats and incidents have not resulted in a material adverse effect, we may incur material losses related to cybersecurity and other threats or incidents in the future. If we were subject to a cybersecurity and other incident, it could have a material adverse effect on our business. Such adverse effects might include:

40

•loss of (or inability to access, e.g. through ransomware) confidential and/or sensitive information stored on these critical information systems or transmitted to or from those systems;

•the disruption of the proper function of our products, services and/or operations;

•the failure of our or our customers’ manufacturing processes;

•errors in the output of our work or our customers’ work;

•the loss or public exposure of the personal information of our employees, customers or other parties;

•the public release of customer orders, financial and business plans, and operational results;

•exposure to claims from third parties who are adversely impacted by such incidents;

•misappropriation or theft of our or a customer’s, supplier’s or other party’s assets or resources, including technology data, intellectual property or other sensitive information and costs associated therewith;

•reputational damage;

•diminution in the value of our investment in research, development and engineering; or

•our failure to meet, or violation of, regulatory or other legal obligations, such as the timely publication or filing of financial statements, tax information and other required communications.

While we have implemented ISO 27001 compliant security procedures and virus protection software, intrusion prevention systems, identity and access control, and emergency recovery processes, and we carefully select our third-party providers of information systems, to mitigate risks to the information systems that we rely on, and to our technology, data, intellectual property and other sensitive information, those security procedures and mitigation and protection systems cannot be guaranteed to be fail-safe and we may still suffer cybersecurity and other incidents. It has been difficult and may continue to be difficult to hire and retain employees with substantial cybersecurity acumen. In addition, there have been and may continue to be instances of our policies and procedures not being effective in enabling us to identify risks, threats and incidents in a timely manner, or at all, or to respond expediently, appropriately and effectively when incidents occur and repair any damage caused by such incidents, and such occurrences could have a material adverse effect on our business.

We Are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification

We derive a substantial percentage of our revenues from a limited number of products. Our products are priced up to approximately $15 million per system. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:

•a decline in demand for even a limited number of our products;

•a failure to achieve continued market acceptance of our key products;

•export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key customers or customers within certain markets;

•an improved version of products being offered by a competitor in the markets in which we participate;

•increased pressure from competitors that offer broader product lines;

•increased pressure from regional competitors;

•technological changes that we are unable to address with our products; or

•a failure to release new or enhanced versions of our products on a timely basis.

In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their business than our competitors that offer additional products and/or product capabilities, including new products that take advantage of “big data” or other new technologies such as machine learning and artificial intelligence. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us to additional risks associated with technology changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger impact on our business than it would on the business of our less concentrated competitors.

We Depend on a Limited Number of Key Suppliers and Outsource Providers, and We Run the Risk That They Might Not Perform as We Expect

Outsource providers and component suppliers have played and will continue to play a key role in our product development, manufacturing operations, field installation and support, and many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties, become subject to exclusivity arrangements that preclude further business with us, or be unable to meet our requirements or expectation due to their independent business decisions or force majeure events that could interrupt or impair their continued ability to perform as we expect.

41

Although we attempt to select reputable providers and suppliers and we attempt to secure their performance on terms documented in written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. There is therefore a risk that a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship products, and generate revenues, which could adversely affect our operating results and damage our customer relationships. For example, the COVID–19 outbreak has impacted and could further impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, "stay at home" orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the outbreak.

We Face Risks Related to the Disruption of Our Primary Manufacturing Facilities

While we maintain business continuity plans, our manufacturing facilities are concentrated in a limited number of locations. These locations are subject to disruption for a variety of reasons, such as natural or man-made disasters, widespread outbreaks of illness, terrorist activities, political or governmental unrest or instability, disruptions of our information technology resources, utility interruptions, the effects of climate change, or other events beyond our control. Such disruptions may cause delays in shipping our products, which could result in the loss of business or customer trust, adversely affecting our business and operating results. For example, the COVID-19 outbreak has impacted and could further impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the outbreak.

Our Future Success Depends Heavily on International Sales and the Management of Global Operations

Non-U.S. sales, as reflected in Part I Item 2. Results of Operations of this quarterly report on Form 10-Q, accounted for approximately 95%, 92%, and 92% of total revenue in the nine months ended March 28, 2021 and fiscal years 2020, and 2019, respectively. We expect that international sales will continue to account for a substantial majority of our total revenue in future years.

We are subject to various challenges related to international sales and the management of global operations including, but not limited to:

•domestic and international trade regulations, policies, practices, relations, disputes and issues;

•domestic and international tariffs, export controls and other barriers;

•developing customers and/or suppliers, who may have limited access to capital resources;

•global or national economic and political conditions;

•changes in currency controls;

•differences in the enforcement of intellectual property and contract rights in varying jurisdictions;

•our ability to respond to customer and foreign government demands for locally sourced systems, spare parts, and services and develop the necessary relationships with local suppliers;

•changes in and compliance with U.S. and international laws and regulations affecting foreign operations, including U.S. and international trade restrictions and sanctions, anti-bribery, anti-corruption, anti-boycott, environmental, tax, and labor laws;

•fluctuations in interest and foreign currency exchange rates;

•the need for technical support resources in different locations; and

•our ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the successful operation of our business.

For example, the COVID–19 outbreak has impacted and could further impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, "stay at home" orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the outbreak.

There is inherent risk, based on the complex relationships among China, Japan, Korea, Taiwan, and the United States, that political, diplomatic and national security influences might lead to trade disputes, impacts and/or disruptions, in particular those affecting the semiconductor industry. This would adversely affect our business with China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region or global economy. A significant trade dispute, impact and/or disruption in any area where we do business could have a materially adverse impact on our future revenue and profits.

42

Tariffs, export controls, additional taxes, trade barriers, sanctions, or the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, may increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, or inhibit our ability to sell products or purchase necessary equipment and supplies, which could have a material adverse effect on our business, results of operations, or financial conditions. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign governments, and our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, could potentially limit the market for our products and adversely impact our revenues. As is discussed below under the heading “Our Sales to Customers in China, a Region of Growing Significance to Us, Could be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China,” the U.S. government has recently expanded export license requirements that impact trade with China. In addition, the U.S. government is in the process of assessing which “emerging and foundational” technologies may be subject to new or additional export controls under the 2018 Export Control Reform Act, and it is possible that such controls, if and when imposed, could adversely impact our ability to sell our products outside the U.S. Furthermore, there are risks that foreign governments may, among other things, insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our revenues and margins.

We are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and expenses denominated in euro, Korean won, Malaysian ringgit, and Indian rupee. Currently, we hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and expenses dominated in euro, Korean won, Malaysian ringgit, and Indian rupee. In addition, we enter into foreign currency hedge contracts to minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities, primarily third-party accounts receivables, accounts payables, and intercompany receivables and payables. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us either over or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues, expenses, monetary assets, and liabilities, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated monetary assets and liabilities (other than those currency exposures previously discussed), and currently we do not enter into foreign currency hedge contracts against these exposures. Therefore, we are subject to potential unfavorable foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany transactions) in these currencies.

The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases, payment of dividends, or the repayment of our notes, can usually only be made with onshore cash balances. Since the majority of our cash is generated outside of the United States, this may impact certain business decisions and outcomes.

Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success

Our ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees with the appropriate skills, experiences and competencies. This is an ongoing challenge due to intense competition for top talent, fluctuations in industry or business economic conditions, as well as increasing geographic expansion, and these factors in combination may result in cycles of hiring activity and workforce reductions. Our success in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs, global economic or political and industry conditions, our organizational structure, global competition for talent and the availability of qualified employees, the availability of career development opportunities, the ability to obtain necessary authorizations for workers to provide services outside their home countries, and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall compensation and benefit programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. If we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities and our operating results may be materially and adversely affected.

We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business

Our success depends in part on our proprietary technology and our ability to protect key components of that technology through patents, copyrights, trade secrets and other forms of protection. Protecting our key proprietary technology helps us achieve our goals of developing technological expertise and new products and systems that give us a competitive advantage; increasing

43

market penetration and growth of our installed base; and providing comprehensive support and service to our customers. As part of our strategy to protect our technology, we currently hold a number of U.S. and foreign patents and pending patent applications, and we keep certain information, processes, and techniques confidential and/or as trade secrets. However, other parties may challenge or attempt to invalidate or circumvent any patents the U.S. or foreign governments issue to us; these governments may fail to issue patents for pending applications; or we may lose trade secret protection over valuable information due to our or third parties’ intentional or unintentional actions or omissions or even those of our own employees. Additionally, intellectual property litigation can be expensive and time-consuming and even when patents are issued, or trade secret processes are followed, the legal systems in certain of the countries in which we do business might not enforce patents and other intellectual property rights as rigorously or effectively as the United States or may favor local entities in their intellectual property enforcement. The rights granted or anticipated under any of our patents, pending patent applications, or trade secrets may be narrower than we expect or, in fact, provide no competitive advantages. Moreover, because we selectively file for patent protection in different jurisdictions, we may not have adequate protection in all jurisdictions based on such filing decisions. Any of these circumstances could have a material adverse impact on our business.

If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance

An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives. As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs, reduced or lost opportunities, and diversion of management’s attention. Managing an acquired business, disposing of product technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management’s attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or technologies, or reduction in personnel, or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, and/or cash flows.

In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, results of operations, cash flows, and/or the price of our Common Stock.

LEGAL, REGULATORY AND TAX RISKS

Our Sales to Customers in China, a Region of Growing Significance to Us, Could be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China

China represents a large and fast-developing market for the semiconductor equipment industry and therefore is important to our business. Revenue in China, which includes global customers and domestic Chinese customers with manufacturing facilities in China, represented approximately 34%, 31%, and 22% of our total revenue for the nine months ended March 28, 2021 and fiscal years 2020 and 2019, respectively. The U.S. and China have historically had a complex relationship that has included actions that have impacted trade between the two countries. Recently, these actions have included an expansion of export license requirements imposed by the U.S. government, which have limited the market for our products, adversely impacted our revenues, and increased our exposure to foreign competition, and could potentially do so to an even greater extent in the future. For example, over the course of calendar year 2020, the U.S. Department of Commerce enacted a new rule that expanded export license requirements for U.S. companies to sell certain items to companies and other end-users in China that are designated as military end-users or have operations that could support military end uses, added additional Chinese companies to its restricted entity list (including Semiconductor Manufacturing International Corporation, or SMIC, and related entities), and expanded an existing rule (referred to as the foreign direct product rule) in a manner that could cause foreign-made wafers, chipsets, and certain related items produced with many of our products to be subject to U.S. licensing requirements if Huawei Technologies Co. Ltd (“Huawei”) or its affiliates are parties to a transaction involving the items. These rules have required and may require us to apply for and obtain additional export licenses to supply certain of our products to specified customers in China, such as SMIC (where those products would not otherwise require an export license to China), and there is no assurance that we will be issued licenses that we apply for on a timely basis or at all. In addition, our customers (including but not limited

44

to Chinese customers) may require U.S. export licenses for the use of our products in order to manufacture products, including semiconductor wafers and integrated circuits, for those of their customers (i.e. Huawei and its affiliates) that are subject to the expanded foreign direct product rule, which may adversely impact the demand for our products. The U.S. Department of Commerce could in the future add additional Chinese companies to its restricted entity list or take other actions that could expand licensing requirements or otherwise impact the market for our products and our revenue. The implementation, interpretation and impact on our business of these rules and other regulatory actions taken by the U.S. government is uncertain and evolving, and these rules, other regulatory actions or changes, and other actions taken by the governments of either the U.S. or China, or both, that have occurred and may occur in the future could materially and adversely affect our results of operations.

Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional Tax Liabilities

We are subject to income, transaction, and other taxes in the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. The amount of taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability. As a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, by material audit assessments, or by changes in or expirations of agreements with tax authorities. These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United States, is dependent on our ability to generate future taxable income in the United States.

We Are Exposed to Various Risks from Our Regulatory Environment

We are subject to various risks related to (1) new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies in the countries that we operate; (2) disagreements or disputes related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including those related to export controls, financial and other disclosures, corporate governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, anti-boycott compliance, conflict minerals or other social responsibility legislation, immigration or travel regulations, antitrust regulations, and laws or regulations relating to carbon emissions, as well as other laws or regulations imposed in response to climate change concerns, among others. Each of these laws, rules, and regulations imposes costs on our business, including financial costs and potential diversion of our management’s attention associated with compliance, and may present risks to our business, including potential fines, restrictions on our actions, and reputational damage if we do not fully comply.

To maintain high standards of corporate governance and public disclosure, we intend to invest appropriate resources to comply with evolving standards. Changes in or ambiguous interpretations of laws, regulations, and standards may create uncertainty regarding compliance matters. Efforts to comply with new and changing regulations have resulted in, and are likely to continue to result in, increased selling, general, and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with the laws and regulations, our business, financial condition, and/or results of operations could be adversely affected.

A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results

We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, and disposal of toxic, volatile, or otherwise hazardous chemicals. Failure to comply with present or future environmental regulations could result in fines being imposed on us, require us to undertake remediation activities, suspend production, and/or cease operations, or cause our customers to not accept our products. These regulations could require us to alter our current operations, acquire significant additional equipment, incur substantial other expenses to comply with environmental regulations, or take other actions. Any failure to comply with regulations governing the use, handling, sale, transport, or disposal of hazardous substances could subject us to future liabilities that may adversely affect our operating results, financial condition, and ability to operate our business.

Intellectual Property, Indemnity, and Other Claims Against Us Can Be Costly and We Could Lose Significant Rights That Are Necessary to Our Continued Business and Profitability

Third parties may assert infringement, misappropriation, unfair competition, product liability, breach of contract, or other claims against us. From time to time, other persons send us notices alleging that our products infringe or misappropriate their patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges relating to intellectual property or other issues. We also face risks of claims arising from commercial and other relationships. In addition,

45

our bylaws and other indemnity obligations provide that we will indemnify officers and members of our Board of Directors against losses that they may incur in legal proceedings resulting from their service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially and adversely affect our business and financial results, and we may be subject to substantial damage awards and penalties. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles.

Our Bylaws Designate the Court of Chancery of the State of Delaware as the Sole and Exclusive Judicial Forum for Certain Legal Actions Between the Company and its Stockholders, Which May Discourage Lawsuits with Respect to Such Claims. 

Our bylaws provide that, unless we consent otherwise, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for lawsuits asserting certain stockholder claims (including claims asserted derivatively for our benefit), such as claims against directors and officers for breach of a fiduciary duty, claims arising under any provision of the General Corporation Law of Delaware or our certificate of incorporation or our bylaws, or claims governed by the internal affairs doctrine. This is a general summary of the bylaw provision; you should refer to the language of the bylaws for details. The forum provision does not apply to actions arising under the Securities Exchange Act of 1934 or the Securities Act of 1933, or related Securities and Exchange Commission rules and regulations. 

As a Delaware corporation, Delaware law controls issues of our internal affairs, including duties that our directors, officers, employees, and others owe to the Company and its stockholders. We believe that our exclusive forum provision benefits us, and our stockholders, by permitting relatively prompt resolution of lawsuits concerning our internal affairs, promoting consistent application of Delaware law in these lawsuits, and reducing the possibility of duplicative, costly, multi-jurisdictional litigation with the potential for inconsistent outcomes. However, the forum provision limits a stockholder’s ability to bring a claim in a judicial forum that it believes may be more favorable than Delaware, and this could discourage the filing of such lawsuits.

FINANCIAL, ACCOUNTING AND CAPITAL MARKETS RISKS

The Market for Our Common Stock Is Volatile, Which May Affect Our Ability to Raise Capital or Make Acquisitions or May Subject Our Business to Additional Costs

The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not within our control or influence. These factors include but are not limited to the following:

•general market, semiconductor, or semiconductor equipment industry conditions;

•economic or political events, trends, and unexpected developments occurring nationally, globally, or in any of our key sales regions;

•variations in our quarterly operating results and financial condition, including our liquidity;

•variations in our revenues, earnings, or other business and financial metrics from forecasts by us or securities analysts or from those experienced by other companies in our industry;

•announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;

•margin trading, short sales, hedging and derivative transactions involving our Common Stock;

•government regulations;

•developments in, or claims relating to, patent or other proprietary rights;

•technological innovations and the introduction of new products by us or our competitors;

•commercial success or failure of our new and existing products; or

•disruptions of relationships with key customers or suppliers.

In addition, the stock market experiences significant price and volume fluctuations. We have witnessed significant volatility in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have adversely affected and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of their stock, many companies became the object of securities

46

class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial performance and the price for our Common Stock.

We May Incur Impairments to Goodwill or Long-lived Assets

We review our long-lived assets, including goodwill and intangible assets identified in business combinations and other intangible assets, for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Negative industry or economic trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business, slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets. If, in any period, our stock price decreases to the point where our fair value, as determined by our market capitalization, is less than the book value of our assets, this could also indicate a potential impairment, and we may be required to record an impairment charge in that period, which could adversely affect our result of operations.

Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment to goodwill in one or more of our business units, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.

Our Leverage and Debt Service Obligations May Adversely Affect Our Financial Condition, Results of Operations, and Earnings per Share

We have $5.8 billion in aggregate principal amount of senior unsecured notes and convertible notes outstanding. Additionally, we have funding available to us under our $1.25 billion commercial paper program and our $1.25 billion revolving credit facility, which serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up to an additional $600.0 million, for a potential total commitment of $1.85 billion. We may, in the future, decide to enter into additional debt arrangements.

In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of nonperformance by the counterparties to our derivative instruments.

Our indebtedness could have adverse consequences, including:

•risk associated with the alternative reference rate reform (e.g. LIBOR transition);

•risk associated with any inability to satisfy our obligations;

•a portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for operations, working capital, capital expenditures, expansion, acquisitions, or general corporate or other purposes; and

•impairment of our ability to obtain additional financing in the future.

Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows, to enable us to meet our expenses and service our debt. As a result, we may need to enter into new financing arrangements to obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default on such debt, and this default could cause us to be in default on our other outstanding indebtedness.

Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business

We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be beneficial to us, or obtain additional financing because our debt agreements contain, and any of our other future similar agreements may contain, covenant restrictions that limit our ability to, among other things:

•incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;

•create liens;

•enter into transactions with our affiliates;

•sell certain assets; and

•merge or consolidate with any person.

47

Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Senior Notes, the Convertible Notes, or our other debt, which could permit the holders to accelerate such debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.

There Can Be No Assurance That We Will Continue to Declare Cash Dividends or Repurchase Our Shares at All or in Any Particular Amounts

Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and periodic determinations by our Board of Directors that cash dividends and share repurchases are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends or the repurchasing of shares by us. Future dividends and share repurchases may also be affected by, among other factors, our views on potential future capital requirements for investments in acquisitions and the funding of our research and development; legal risks; changes in federal, state, and international tax laws or corporate laws; contractual restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments or share repurchases could have a negative effect on the price of our Common Stock.

ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Company Shares

In November 2020, the Board of Directors authorized management to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balance from any prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Share repurchases, including those under the repurchase program, were as follows:

	Total Number of Shares Repurchased (1)	Average Price Paid Per Share (2)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 28, 2020					$	1,773,427
Quarter ended September 27, 2020	1,359	$	343.71	1,344	1,311,429
Quarter ended December 27, 2020	1,797	$	405.00	1,789	5,586,944
December 28, 2020 - January 24, 2021	367	$	516.96	366	5,397,950
January 25, 2021 - February 21, 2021	1,026	$	519.37	1,022	4,707,718
February 22, 2021 - March 28, 2021	338	$	577.30	86	4,661,845
Quarter ended March 28, 2021	1,731	$	536.75	1,474	$	4,661,845

(1)    During the three and nine months ended March 28, 2021, we acquired 257 thousand shares at a total cost of $152.3 million and 280 thousand shares at a total cost of $160.6 million, respectively, which we withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under our equity compensation plans. The shares retained by us through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under our equity compensation plan.

(2)     Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding our accelerated share repurchase activity during the nine months ended March 28, 2021.

Accelerated Share Repurchase Agreements

On February 11, 2021, we entered into an accelerated share repurchase agreement (the "February 2021 ASR") with a financial institution to repurchase a total of $500 million of Common Stock. We took an initial delivery of approximately 655 thousand

48

shares, which represented 75% of the prepayment amount divided by our closing stock price on February 11, 2021. The total number of shares received under the February 2021 ASR will be based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the February 2021 ASR will occur no later than June 9, 2021.

ITEM 3.    Defaults Upon Senior Securities

None.

ITEM 4.    Mine Safety Disclosures

Not applicable.

ITEM 5.    Other Information

None.

49

ITEM 6.    Exhibits

Exhibit Number	Description
10.1*	Executive Severance Policy which is incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 28, 2020 (SEC File No. 000-12933).
10.2*	Executive Change in Control Policy which is incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on December 28, 2020 (SEC File No. 000-12933).
31.1	Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2	Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer)
32.1	Section 1350 Certification (Principal Executive Officer)
32.2	Section 1350 Certification (Principal Financial Officer)
101.INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
	*Indicates management contract of compensatory plan or arrangement in which executive officers of the Company are eligible to participate.

50

LAM RESEARCH CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	April 28, 2021	LAM RESEARCH CORPORATION (Registrant)
		/s/ Douglas R. Bettinger
		Douglas R. Bettinger
		Executive Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

51

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

I, Timothy M. Archer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 28, 2021

/s/ Timothy M. Archer

Timothy M. Archer

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

I, Douglas R. Bettinger, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 28, 2021

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President, Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

EX-32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending March 28, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy M. Archer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 28, 2021

/s/ Timothy M. Archer

Timothy M. Archer

President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

SECTION 1350 CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending March 28, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas R. Bettinger, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 28, 2021

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President, Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Cover Page - shares	9 Months Ended
	Mar. 28, 2021	Apr. 26, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 28, 2021
Document Transition Report	false
Entity File Number	0-12933
Entity Registrant Name	LAM RESEARCH CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-2634797
Entity Address, Address Line One	4650 Cushing Parkway,
Entity Address, City or Town	Fremont,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	572-0200
Title of 12(b) Security	Common Stock, Par Value $0.001 Per Share
Trading Symbol	LRCX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		142,619,346
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000707549
Current Fiscal Year End Date	--06-27

XML

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Income Statement [Abstract]
Revenue	$ 3,847,654	$ 2,503,625	$ 10,480,971	$ 7,252,872
Cost of goods sold	2,067,523	1,336,618	5,590,866	3,924,511
Gross margin	1,780,131	1,167,007	4,890,105	3,328,361
Research and development	381,120	307,914	1,111,659	913,602
Selling, general, and administrative	203,703	164,979	612,350	496,679
Total operating expenses	584,823	472,893	1,724,009	1,410,281
Operating income	1,195,308	694,114	3,166,096	1,918,080
Other expense, net	(35,320)	(64,619)	(104,053)	(91,271)
Income before income taxes	1,159,988	629,495	3,062,043	1,826,809
Income tax expense	(88,867)	(54,714)	(298,242)	(271,729)
Net income	$ 1,071,121	$ 574,781	$ 2,763,801	$ 1,555,080
Net income per share:
Basic (in dollars per share)	$ 7.51	$ 3.96	$ 19.20	$ 10.75
Diluted (in dollars per share)	$ 7.41	$ 3.88	$ 18.94	$ 10.39
Number of shares used in per share calculations:
Basic (in shares)	142,676	145,301	143,925	144,654
Diluted (in shares)	144,609	148,165	145,923	149,648

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 1,071,121	$ 574,781	$ 2,763,801	$ 1,555,080
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(13,701)	(18,225)	20,231	(19,412)
Cash flow hedges:
Net unrealized gains (losses) during the period	8,024	(29,456)	12,546	(26,068)
Net (gains) losses reclassified into net income	(207)	(924)	843	1,810
Net change	7,817	(30,380)	13,389	(24,258)
Available-for-sale investments:
Net unrealized losses during the period	(1,623)	(4,129)	(3,667)	(6,842)
Net losses reclassified into net income	162	27	727	1,010
Net change	(1,461)	(4,102)	(2,940)	(5,832)
Defined benefit plans, net change in unrealized component	174	278	234	856
Other comprehensive (loss) income, net of tax	(7,171)	(52,429)	30,914	(48,646)
Comprehensive income	$ 1,063,950	$ 522,352	$ 2,794,715	$ 1,506,434

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020	[1]
ASSETS
Cash and cash equivalents	$ 3,673,366	$ 4,915,172
Investments	2,116,101	1,795,080
Accounts receivable, less allowance of $5,191 as of March 28, 2021, and $5,465 as of June 28, 2020	2,809,068	2,097,099
Inventories	2,552,032	1,900,024
Prepaid expenses and other current assets	171,703	146,160
Total current assets	11,322,270	10,853,535
Property and equipment, net	1,279,836	1,071,499
Restricted cash and investments	253,460	253,911
Goodwill	1,489,990	1,484,436
Intangible assets, net	143,264	168,532
Other assets	796,093	727,134
Total assets	15,284,913	14,559,047
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	760,942	592,387
Accrued expenses and other current liabilities	1,292,174	1,272,655
Deferred profit	733,783	457,523
Current portion of long-term debt and finance lease obligations	825,434	839,877
Total current liabilities	3,612,333	3,162,442
Long-term debt and finance lease obligations, less current portion	4,991,613	4,970,848
Income taxes payable	924,629	909,709
Other long-term liabilities	381,505	332,559
Total liabilities	9,910,080	9,375,558
Commitments and contingencies
Temporary equity, convertible notes	3,217	10,995
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding	0	0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 28, 2021 and June 28, 2020; issued and outstanding, 142,607 shares at March 28, 2021, and 145,331 shares at June 28, 2020	143	145
Additional paid-in capital	6,922,023	6,695,858
Treasury stock, at cost; 150,111 shares at March 28, 2021, and 145,432 shares at June 28, 2020	(15,212,934)	(12,949,889)
Accumulated other comprehensive loss	(63,297)	(94,211)
Retained earnings	13,725,681	11,520,591
Total stockholders’ equity	5,371,616	5,172,494
Total liabilities and stockholders’ equity	$ 15,284,913	$ 14,559,047

[1] Derived from audited financial statements

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 5,191	$ 5,465
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	142,607,000	145,331,000
Common stock, shares outstanding (in shares)	142,607,000	145,331,000
Treasury stock, shares (in shares)	150,111,000	145,432,000

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,763,801	$ 1,555,080
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	228,754	197,442
Deferred income taxes	(5,448)	74,516
Equity-based compensation expense	163,843	136,044
Amortization of note discounts and issuance costs	4,251	4,611
Other, net	6,143	11,510
Changes in operating assets and liabilities	(1,009,116)	(665,800)
Net cash provided by operating activities	2,152,228	1,313,403
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(244,474)	(152,685)
Purchases of available-for-sale securities	(3,242,741)	(1,889,823)
Maturities of available-for-sales securities	1,951,037	1,163,555
Sales of available-for-sale securities	956,261	1,065,618
Other, net	(35,873)	(540)
Net cash (used for) provided by investing activities	(615,790)	186,125
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(40,014)	(664,589)
Proceeds from borrowings on revolving credit facility	0	1,250,000
Treasury stock purchases	(2,266,449)	(1,328,632)
Dividends paid	(541,607)	(489,099)
Reissuance of treasury stock related to employee stock purchase plan	41,434	38,447
Proceeds from issuance of common stock	23,272	6,215
Other, net	(1,844)	328
Net cash used for financing activities	(2,785,208)	(1,187,330)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	6,513	(9,853)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(1,242,257)	302,345
Cash, cash equivalents, and restricted cash at beginning of period	5,169,083	3,913,396
Cash, cash equivalents, and restricted cash at end of period	3,926,826	4,215,741
Schedule of non-cash transactions:
Accrued payables for stock repurchases	5,855	295
Accrued payables for capital expenditures	80,215	29,690
Transfers of inventory to property and equipment, net	59,882	34,155
Reconciliation of cash, cash equivalents, and restricted cash
Total cash, cash equivalents, and restricted cash	$ 3,926,826	$ 4,215,741

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total		Cumulative effect adjustment		Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings	Retained Earnings Cumulative effect adjustment
Beginning balance (in shares) at Jun. 30, 2019					144,433
Beginning balance at Jun. 30, 2019	$ 4,673,865		$ 3,018		$ 144	$ 6,409,405	$ (11,602,573)	$ (64,030)	$ 9,930,919	$ 3,018
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)					1,230
Issuance of common stock	6,215				$ 1	6,214
Purchase of treasury stock (in shares)					(5,215)
Purchase of treasury stock	(1,328,898)				$ (4)		(1,328,894)
Reissuance of treasury stock (in shares)					296
Reissuance of treasury stock	38,447					25,710	12,737
Equity-based compensation expense	136,044					136,044
Effect of conversion of convertible notes (in shares)					4,412
Effect of conversion of convertible notes	(37,440)				$ 4	(37,444)
Reclassification from temporary to permanent equity	37,893					37,893
Net income	1,555,080								1,555,080
Other comprehensive income (loss)	(48,646)							(48,646)
Cash dividends declared	(497,971)								(497,971)
Ending balance (in shares) at Mar. 29, 2020					145,156
Ending balance at Mar. 29, 2020	4,537,607				$ 145	6,577,822	(12,918,730)	(112,676)	10,991,046
Beginning balance (in shares) at Dec. 29, 2019					142,462
Beginning balance at Dec. 29, 2019	4,379,429				$ 142	6,528,821	(12,673,292)	(60,247)	10,584,005
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)					1,047
Issuance of common stock	1,714				$ 1	1,713
Purchase of treasury stock (in shares)					(1,576)
Purchase of treasury stock	(245,439)				$ (1)		(245,438)
Equity-based compensation expense	47,414					47,414
Effect of conversion of convertible notes (in shares)					3,223
Effect of conversion of convertible notes	(26,881)				$ 3	(26,884)
Reclassification from temporary to permanent equity	26,758					26,758
Net income	574,781								574,781
Other comprehensive income (loss)	(52,429)							(52,429)
Cash dividends declared	(167,740)								(167,740)
Ending balance (in shares) at Mar. 29, 2020					145,156
Ending balance at Mar. 29, 2020	4,537,607				$ 145	6,577,822	(12,918,730)	(112,676)	10,991,046
Beginning balance (in shares) at Jun. 28, 2020					145,331
Beginning balance at Jun. 28, 2020	5,172,494	[1]	$ 1,157	[2]	$ 145	6,695,858	(12,949,889)	(94,211)	11,520,591	$ 1,157	[2]
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)					1,053
Issuance of common stock	23,272				$ 1	23,271
Purchase of treasury stock (in shares)					(4,887)
Purchase of treasury stock	(2,272,222)				$ (4)		(2,272,218)
Reissuance of treasury stock (in shares)					207
Reissuance of treasury stock	41,434					32,261	9,173
Equity-based compensation expense	163,843					163,843
Effect of conversion of convertible notes (in shares)					903
Effect of conversion of convertible notes	(987)				$ 1	(988)
Reclassification from temporary to permanent equity	7,778					7,778
Net income	2,763,801								2,763,801
Other comprehensive income (loss)	30,914							30,914
Cash dividends declared	(559,868)								(559,868)
Ending balance (in shares) at Mar. 28, 2021					142,607
Ending balance at Mar. 28, 2021	5,371,616				$ 143	6,922,023	(15,212,934)	(63,297)	13,725,681
Beginning balance (in shares) at Dec. 27, 2020					143,205
Beginning balance at Dec. 27, 2020	5,503,033				$ 143	6,854,681	(14,135,555)	(56,126)	12,839,890
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)					848
Issuance of common stock	9,626				$ 1	9,625
Purchase of treasury stock (in shares)					(1,731)
Purchase of treasury stock	(1,077,380)				$ (1)		(1,077,379)
Equity-based compensation expense	55,746					55,746
Effect of conversion of convertible notes (in shares)					285
Effect of conversion of convertible notes	(327)					(327)
Reclassification from temporary to permanent equity	2,298					2,298
Net income	1,071,121								1,071,121
Other comprehensive income (loss)	(7,171)							(7,171)
Cash dividends declared	(185,330)								(185,330)
Ending balance (in shares) at Mar. 28, 2021					142,607
Ending balance at Mar. 28, 2021	$ 5,371,616				$ 143	$ 6,922,023	$ (15,212,934)	$ (63,297)	$ 13,725,681

[1] Derived from audited financial statements

[2] (1) Refer to Note 2 - Recent Accounting Pronouncements for more information regarding this Financial Accounting Standards Board (FASB) Accounting Standard Updates.

XML

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended				9 Months Ended		12 Months Ended
	Mar. 28, 2021	Jun. 28, 2020	[1]	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020	Jun. 30, 2019
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (in dollars per share)	$ 1.30			$ 1.15	$ 3.90	$ 3.45
Accounting Standards Update		us-gaap:AccountingStandardsUpdate201818Member					us-gaap:AccountingStandardsUpdate201602Member

[1] (1) Refer to Note 2 - Recent Accounting Pronouncements for more information regarding this Financial Accounting Standards Board (FASB) Accounting Standard Updates.

XML

BASIS OF PRESENTATION

9 Months Ended

Mar. 28, 2021

Accounting Policies [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 28, 2020, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 28, 2020 (the “2020 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 27, 2021 and includes 52 weeks. The quarters ended March 28, 2021 (the “March 2021 quarter”) and March 29, 2020 (the “March 2020 quarter”) included 13 weeks.

XML

RECENT ACCOUNTING PRONOUNCEMENTS

9 Months Ended

Mar. 28, 2021

Accounting Changes and Error Corrections [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted

In June 2016, the Financial Accounting Standards Board (“FASB”) released Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326).” The amendment revises the impairment model to utilize an expected loss methodology in place of the previously used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The FASB issued a subsequent amendment to the initial guidance in April 2019 and November 2019 within ASU 2019-04 and ASU 2019-11, respectively. The adoption of these standards in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In November 2018, the FASB issued ASU 2018-18, “Collaborative Arrangements (Topic 808).” The amendment clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606 when the counterparty is a customer for a good or service that is a distinct unit of account. The amendment also precludes entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The adoption of this standard in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “ Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company has not yet applied the relief afforded by these standard amendments and is currently assessing contracts that will require modification due to reference rate reform to which these standard amendments may be applied.

Updates Not Yet Adopted or EffectiveIn August 2020, the FASB issued ASU No. 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. ASU 2020-06 also eliminates the treasury stock method to calculate diluted earnings per share and requires the if-converted method. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is required to adopt this standard in the first quarter of fiscal year 2023. The update permits the use of either the modified retrospective or fully retrospective method of transition. The Company does not expect adoption of this standard to have a material impact on its Consolidated Financial Statements related to the Company’s existing 2041 Notes (as defined in Note 12 - Long-Term Debt and Other Borrowings ).

XML

REVENUE

9 Months Ended

Mar. 28, 2021

Revenue from Contract with Customer [Abstract]

REVENUE

REVENUE

Deferred Revenue

Revenue of $69.1 million and $427.2 million included in deferred revenue as of June 28, 2020 was recognized during the three and nine months ended March 28, 2021.

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 28, 2021 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years		Total
	(In thousands)
Deferred revenue	$	661,240	$	156,040	(1)	$	—	$	817,280

(1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Disaggregation of Revenue

The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution.

The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing.

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
System revenue	$	2,545,306	$	1,647,560	$	7,000,968	$	4,759,881
Customer support-related revenue and other	1,302,348		856,065		3,480,003		2,492,991
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant product line.

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
China	$	1,217,427	$	792,412	$	3,600,281	$	2,142,366
Korea	1,195,711		589,072		2,664,493		1,503,733
Taiwan	545,719		515,485		1,576,109		1,587,848
Japan	262,913		239,751		999,462		721,664
Southeast Asia	260,360		62,800		829,157		460,723
United States	184,887		215,015		460,271		622,399
Europe	180,637		89,090		351,198		214,139
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Memory	62	%	56	%	62	%	57	%
Foundry	31	%	31	%	31	%	31	%
Logic/integrated device manufacturing	7	%	13	%	7	%	12	%

XML

EQUITY-BASED COMPENSATION PLANS

9 Months Ended

Mar. 28, 2021

Share-based Payment Arrangement [Abstract]

EQUITY-BASED COMPENSATION PLANS

EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Equity-based compensation expense	$	55,746	$	47,414	$	163,843	$	136,044
Income tax benefit recognized related to equity-based compensation expense	$	44,077	$	24,457	$	63,866	$	38,736

XML

OTHER EXPENSE, NET

9 Months Ended

Mar. 28, 2021

Other Income and Expenses [Abstract]

OTHER EXPENSE, NET

OTHER EXPENSE, NET

The significant components of other expense, net, are as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Interest income	$	4,209	$	18,856	$	15,964	$	76,094
Interest expense	(52,236)		(41,580)		(156,902)		(128,190)
Gains (losses) on deferred compensation plan-related assets, net	7,520		(33,828)		44,654		(20,135)
Foreign exchange gains (losses), net	541		480		(4,597)		(2,336)
Other, net	4,646		(8,547)		(3,172)		(16,704)
	$	(35,320)	$	(64,619)	$	(104,053)	$	(91,271)

XML

INCOME TAX EXPENSE

9 Months Ended

Mar. 28, 2021

Income Tax Disclosure [Abstract]

INCOME TAX EXPENSE

INCOME TAX EXPENSE

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 28, 2021			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Income tax expense	$	88,867		$	54,714		$	298,242		$	271,729
Effective tax rate	7.7		%	8.7		%	9.7		%	14.9		%

The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three and nine months ended March 28, 2021 and the three and nine months ended March 29, 2020 was primarily due to income in lower tax jurisdictions, stock-based compensation excess tax benefits, and a cumulative income tax benefit reversal due to a court ruling in the nine months ended March 29, 2020.

The Internal Revenue Service (“IRS”) is examining the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of March 28, 2021, no significant adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur.

The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its uncertain tax positions as a result of tax examinations or lapses of statutes of limitations. The change in uncertain tax positions as a result of lapses of statutes of limitations may range up to $7.4 million.

XML

NET INCOME PER SHARE

9 Months Ended

Mar. 28, 2021

Earnings Per Share [Abstract]

NET INCOME PER SHARE

NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, and convertible notes. Refer to Note 12 - Long-term Debt and Other Borrowings for additional information regarding the Company’s convertible notes. The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands, except per share data)
Numerator:
Net income	$	1,071,121	$	574,781	$	2,763,801	$	1,555,080
Denominator:
Basic average shares outstanding	142,676		145,301		143,925		144,654
Effect of potential dilutive securities:
Employee stock plans	1,415		1,453		1,273		1,390
Convertible notes	518		1,411		725		3,604
Diluted average shares outstanding	144,609		148,165		145,923		149,648
Net income per share - basic	$	7.51	$	3.96	$	19.20	$	10.75
Net income per share - diluted	$	7.41	$	3.88	$	18.94	$	10.39

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:

	Three Months Ended		Nine Months Ended
	March 28, 2021	March 29, 2020	March 28, 2021	March 29, 2020
	(in thousands)
Options and RSUs	120	40	40	13

XML

FINANCIAL INSTRUMENTS

9 Months Ended

Mar. 28, 2021

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other expense, net in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses associated with market valuation changes, unrelated to credit losses, reported as a separate component of accumulated other comprehensive income (loss), net of tax; and credit losses, if any, recognized as other expense, net in the Condensed Consolidated Statements of Operations.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company engages with pricing vendors to provide fair values for a majority of its Level 1 and Level 2 investments. The vendors provide either a quoted market price in an active market or use observable inputs without applying significant adjustments in their pricing. Significant observable inputs include interest rates and yield curves observable at commonly quoted intervals, volatility and credit risks. The fair value of derivative contracts is determined using observable market inputs such as the foreign currency rates, forward rate curves, currency volatility and interest rates and considers nonperformance risk of the Company and its counterparties.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. Refer to Note 12 - Long-Term Debt and Other Borrowings for additional information regarding the fair value of the Company’s senior notes and convertible senior notes.

Investments

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 28, 2021, and June 28, 2020:

	March 28, 2021
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	753,473	$	—	$	—	$	753,473	$	750,040	$	—	$	3,433	$	—
Time deposits	1,349,934		—		—		1,349,934		1,099,907		—		250,027		—
Level 1:
Money market funds	1,638,280		—		—		1,638,280		1,638,280		—		—		—
U.S. Treasury and agencies	385,461		209		(13)		385,657		—		385,657		—		—
Mutual funds	84,377		10,471		(105)		94,743		—		—		—		94,743
Level 1 Total	2,108,118		10,680		(118)		2,118,680		1,638,280		385,657		—		94,743
Level 2:
Government-sponsored enterprises	3,500		12		—		3,512		—		3,512		—		—
Foreign government bonds	47,099		43		(1)		47,141		—		47,141		—		—
Corporate notes and bonds	1,844,375		2,569		(633)		1,846,311		185,139		1,661,172		—		—
Mortgage backed securities — residential	6,279		74		—		6,353		—		6,353		—		—
Mortgage backed securities — commercial	12,264		33		(31)		12,266		—		12,266		—		—
Level 2 Total	1,913,517		2,731		(665)		1,915,583		185,139		1,730,444		—		—
Total	$	6,125,042	$	13,411	$	(783)	$	6,137,670	$	3,673,366	$	2,116,101	$	253,460	$	94,743

	June 28, 2020
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	977,862	$	—	$	—	$	977,862	$	973,978	$	—	$	3,884	$	—
Time deposits	2,244,655		—		—		2,244,655		1,994,628		—		250,027		—
Level 1:
Money market funds	1,709,350		—		—		1,709,350		1,709,350		—		—		—
U.S. Treasury and agencies	552,088		373		(9)		552,452		76,992		475,460		—		—
Mutual funds	68,784		4,571		(928)		72,427		—		—		—		72,427
Level 1 Total	2,330,222		4,944		(937)		2,334,229		1,786,342		475,460		—		72,427
Level 2:
Government-sponsored enterprises	31,442		12		—		31,454		25,999		5,455		—		—
Foreign government bonds	10,693		28		(5)		10,716		2,540		8,176		—		—
Corporate notes and bonds	1,405,615		5,344		(302)		1,410,657		131,685		1,278,972		—		—
Mortgage backed securities — residential	3,142		71		—		3,213		—		3,213		—		—
Mortgage backed securities — commercial	23,660		144		—		23,804		—		23,804		—		—
Level 2 Total	1,474,552		5,599		(307)		1,479,844		160,224		1,319,620		—		—
Total	$	7,027,291	$	10,543	$	(1,244)	$	7,036,590	$	4,915,172	$	1,795,080	$	253,911	$	72,427

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments.

Following the adoption of Accounting Standard Codification Topic 326 (see additional information in Note 2 - Recent Accounting Pronouncements), under Subtopic 326-30, the Company evaluates its investments with fair value less than amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference between fair value and amortized cost is recognized as a loss in the income statement. Where such sales are not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the result of credit losses, those amounts are recognized in the income statement. All other differences between fair value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the income statement during the three and nine months ended March 28, 2021.

The Company did not recognize any losses on investments due to other-than-temporary impairments during the three and nine months ended March 29, 2020. Gross realized gains/(losses) from sales of investments were insignificant in the three and nine months ended March 28, 2021 and March 29, 2020.

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions; as of March 28, 2021 there are no unrealized loss positions with a duration equal to or greater than twelve months:

	March 28, 2021
	Unrealized Losses Less than 12 Months
	Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	7,958	$	(13)
Municipal notes and bonds	6,468		(105)
Foreign government bonds	21,259		(1)
Corporate notes and bonds	540,915		(633)
Mortgage backed securities — commercial	7,599		(31)
	$	584,199	$	(783)

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 28, 2021:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,270,859	$	4,271,415
Due after one year through five years	967,417		969,055
Due in more than five years	48,916		48,984
	$	5,287,192	$	5,289,454

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.

Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of March 28, 2021 and June 28, 2020, the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be immaterial to the Condensed Consolidated Balance Sheets.

Cash Flow Hedges

The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items affect earnings.

In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive income (loss) and is amortized into income as the hedged item impacts earnings.

At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign exchange contracts due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not

believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately.

As of March 28, 2021 and June 28, 2020, the fair value of outstanding cash flow hedges was not material. Additionally, as of March 28, 2021, the Company had an immaterial net gain or loss accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges and interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 12 months.

The following table provides the total notional value of cash flow hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	328,737
Sell Contracts	352,034

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”), was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021				March 28, 2021
	Location of  Gain or (Loss) Recognized in or Reclassified into Net Income	Gain (Loss) Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income		Gain Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	15,285	$	(1,323)	$	6,948	$	(3,598)
Foreign Exchange Contracts	Cost of goods sold	(3,473)		1,355		3,429		3,073
Foreign Exchange Contracts	Research and Development	(1,319)		—		950		—
Foreign Exchange Contracts	Selling, general, and administrative	(1,741)		1,326		4,056		2,649
Interest Rate Contracts	Other expense, net	—		(962)		—		(2,871)
		$	8,752	$	396	$	15,383	$	(747)

		Three Months Ended				Nine Months Ended
		March 29, 2020				March 29, 2020
	Location of  Gain or (Loss) Recognized in or Reclassified into Income	Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income		Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	6,334	$	1,279	$	9,532	$	773
Foreign Exchange Contracts	Cost of goods sold	(2,589)		(186)		(3,656)		(2,086)
Foreign Exchange Contracts	Selling, general, and administrative	(1,394)		6		(1,859)		(887)
Interest Rate Contracts	Other expense, net	(40,901)		(36)		(38,507)		(106)
		$	(38,550)	$	1,063	$	(34,490)	$	(2,306)

Balance Sheet Hedges

The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other expense, net and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other expense, net. As of March 28, 2021 and June 28, 2020, the fair value of outstanding balance sheet hedges was not material.

The following table provides the total notional value of balance sheet hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	150,554
Sell Contracts	154,595

The effect of the Company’s balance sheet hedge derivative instruments on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Net Income		Loss Recognized in Net Income		Gain Recognized in Net Income		Loss Recognized in Net Income
		(in thousands)
Foreign Exchange Contracts	Other expense, net	$	2,992	$	(6,858)	$	6,895	$	(8,788)

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions, and, to date, no such counterparty has failed to meet its financial obligations to the Company.

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

XML

INVENTORIES

9 Months Ended

Mar. 28, 2021

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Raw materials	$	1,437,563	$	1,161,961
Work-in-process	359,402		251,199
Finished goods	755,067		486,864
	$	2,552,032	$	1,900,024

XML

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Mar. 28, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.5 billion as of March 28, 2021 and June 28, 2020. As of March 28, 2021 and June 28, 2020, $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.

Intangible Assets

The following table provides the Company’s intangible assets, other than goodwill:

	March 28, 2021						June 28, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	630,278	$	(569,203)	$	61,075	$	630,137	$	(532,550)	$	97,587
Existing technology	669,302		(658,632)		10,670		668,992		(654,382)		14,610
Patents and other intangible assets	125,383		(53,864)		71,519		98,342		(42,007)		56,335
Total intangible assets	$	1,424,963	$	(1,281,699)	$	143,264	$	1,397,471	$	(1,228,939)	$	168,532

The Company recognized $17.9 million and $16.6 million in intangible asset amortization expense during the three months ended March 28, 2021 and March 29, 2020, respectively. The Company recognized $52.3 million and $49.3 million in intangible asset amortization expense during the nine months ended March 28, 2021 and March 29, 2020, respectively.

The estimated future amortization expense of intangible assets as of March 28, 2021, is reflected in the table below. The table excludes $13.9 million of capitalized costs for internal-use software that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2021 (remaining 3 months)	$	18,019
2022	68,138
2023	22,274
2024	12,089
2025	6,681
Thereafter	2,164
	$	129,365

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

9 Months Ended

Mar. 28, 2021

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Accrued compensation	$	442,188	$	402,401
Warranty reserves	156,059		117,839
Income and other taxes payable	99,021		215,652
Dividend payable	185,390		167,129
Other	409,516		369,634
	$	1,292,174	$	1,272,655

XML

LONG-TERM DEBT AND OTHER BORROWINGS

9 Months Ended

Mar. 28, 2021

Debt Disclosure [Abstract]

LONG-TERM DEBT AND OTHER BORROWINGS

LONG-TERM DEBT AND OTHER BORROWINGS

As of March 28, 2021, and June 28, 2020, the Company’s outstanding debt consisted of the following:

	March 28, 2021					June 28, 2020
	Amount (in thousands)			Effective Interest Rate		Amount (in thousands)			Effective Interest Rate
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000			2.95	%	800,000			2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000			3.87	%	500,000			3.87	%
Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes")	750,000			3.86	%	750,000			3.86	%
Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes")	1,000,000			4.09	%	1,000,000			4.09	%
Fixed-rate 1.90% Senior Note Due June 15, 2030 ("2030 Notes")	750,000			2.01	%	750,000			2.01	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	17,289		(1)	4.28	%	48,460		(1)	4.28	%
Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes")	750,000			4.93	%	750,000			4.93	%
Fixed-rate 2.875% Senior Note Due June 15, 2050 ("2050 Notes")	750,000			2.93	%	750,000			2.93	%
Fixed-rate 3.125% Senior Note Due June 15, 2060 ("2060 Notes")	500,000			3.18	%	500,000			3.18	%
Total debt outstanding, at par	5,817,289					5,848,460
Unamortized discount	(42,443)					(53,086)
Fair value adjustment - interest rate contracts	7,066		(2)			8,405		(2)
Unamortized bond issuance costs	(7,649)					(8,301)
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478
Reported as:
Current portion of long-term debt	$	813,786				$	836,107
Long-term debt	4,960,477					4,959,371
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478

____________________________

(1) As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Condensed Consolidated Balance Sheets. Additionally, on March 26, 2021, the Company issued a notice of redemption to the existing bondholders, with a redemption date of May 21, 2021.

(2) This amount represents a cumulative fair value gain for discontinued hedging relationships, net of an immaterial amount of amortization as of the periods presented.

Convertible Senior Notes

In June 2012, with the acquisition of Novellus Systems, Inc., the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 15, 2041. The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.

The Company separately accounts for the liability and equity components of the 2041 Notes. The initial debt components of the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table above, respectively. The equity component was initially valued equal to the principal value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.

During the three months ended March 28, 2021, the Company notified holders of the 2041 Notes of its intention to exercise the redemption option pursuant to Section 6.01 of the underlying indenture. As such, the 2041 Notes outstanding on May 21, 2021 will be redeemed by the Company at a price equal to outstanding principal plus accrued and unpaid interest.

Under certain circumstances, the 2041 Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of the 2041 Note conversions in the three and nine months ended March 28, 2021, was approximately $9.6 million and $31.2 million, respectively. As a result of the cumulative conversions, as of March 28, 2021, $17.3 million of the 2041 notes remain outstanding.

During the three months ended March 28, 2021 and in the subsequent period through April 28, 2021, the Company received notices of conversion for an immaterial principal value of 2041 Notes, which will settle in the three months ending June 27, 2021.

Selected additional information regarding the 2041 Notes outstanding as of March 28, 2021, and June 28, 2020, is as follows:

	March 28, 2021		June 28, 2020
	2041 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	161,612	$	161,467
Carrying amount of temporary equity component, net of tax	$	3,217	$	10,995
Remaining amortization period (years)	20.1		20.9
Fair Value of Notes (Level 2)	$	319,495
Conversion rate (shares of common stock per $1,000 principal amount of notes)	31.8009
Conversion price (per share of common stock)	$	31.45
If-converted value in excess of par value	$	303,924
Estimated share dilution using average quarterly stock price $538.79 per share	518

Senior Notes

On May 5, 2020, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due June 15, 2030 (the “2030 Notes”), $750 million aggregate principal amount of the Company’s Senior Notes due June 15, 2050 (the “2050 Notes”), and $500 million aggregate principal amount of the Company’s Senior Notes due June 15, 2060 (the “2060 Notes”). The Company pays interest at an annual rate of 1.90%, 2.875%, and 3.125%, on the 2030, 2050, and 2060 Notes, respectively, on a semi-annual basis on June 15 and December 15 of each year.

On March 4, 2019, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2026 (the “2026 Notes”), $1.0 billion aggregate principal amount of the Company’s Senior Notes due March 15, 2029 (the “2029 Notes”), and $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2049 (the “2049 Notes”). The Company pays interest at an annual rate of 3.75%, 4.00%, and 4.875%, on the 2026, 2029, and 2049 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year.

On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2025 (the “2025 Notes”). The Company pays interest at an annual rate of 3.80% on the 2025 Notes on a semi-annual basis on March 15 and September 15 of each year.

On June 7, 2016, the Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year.

The Company may redeem the 2021, 2025, 2026, 2029, 2030, 2049, 2050, and 2060 Notes (collectively the “Senior Notes”) at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the Senior Notes and accrued and unpaid interest before May 15, 2021 for the 2021 Notes, before December 15, 2024 for the 2025 Notes, before January 15, 2026 for the 2026 Notes, before December 15, 2028 for the 2029 Notes, before March 15, 2030 for the 2030 Notes, before September 15, 2048 for the 2049 Notes, before December 15, 2049 for the 2050 Notes, and before December 15, 2059 for the 2060 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021 for the 2021 Notes, on or after December 24, 2024 for the 2025 Notes, on or after January 15, 2026 for the 2026 Notes, on or after December 15, 2028 for the 2029 Notes, on or after March 15, 2030 for the 2030 Notes, on or after September 15, 2048 for the 2049 Notes, on or after December 15, 2049 for the 2050 Notes, and on or after December 15, 2059 for the 2060 Notes. In addition, upon the occurrence of certain events, as

described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.

Selected additional information regarding the Senior Notes outstanding as of March 28, 2021, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2021 Notes	0.2	$	802,480
2025 Notes	4.0	$	550,435
2026 Notes	5.0	$	835,095
2029 Notes	8.0	$	1,139,390
2030 Notes	9.2	$	729,968
2049 Notes	28.0	$	973,500
2050 Notes	29.2	$	711,263
2060 Notes	39.2	$	484,215

Revolving Credit Facility

On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), and February 25, 2019 (the “3rd Amendment”). Under the Amended and Restated Credit Agreement (as amended by the 2nd and 3rd Amendment), the Company has a revolving credit facility of $1.25 billion with a syndicate of lenders with an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600.0 million, for a potential total commitment of $1.85 billion. The facility matures on October 13, 2022.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Amended and Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default. As of March 28, 2021, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

Commercial Paper Program

On November 13, 2017, the Company established a commercial paper program (“the CP Program”) under which the Company may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate principal amount of $1.25 billion. The net proceeds from the CP Program will be used for general corporate purposes, including repurchases of the Company’s Common Stock from time to time under the Company’s stock repurchase program. Amounts available under the CP Program may be re-borrowed. The CP Program is backstopped by the Company’s Revolving Credit Arrangement. As of March 28, 2021 and June 28, 2020, the Company had no outstanding borrowings under the CP Program.

Interest Cost

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, commercial paper, and the revolving credit facility during the three and nine months ended March 28, 2021 and March 29, 2020.

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Contractual interest coupon	$	49,487	$	40,409	$	148,573	$	122,196
Amortization of interest discount	998		953		3,011		3,346
Amortization of issuance costs	414		408		1,238		1,238
Effect of interest rate contracts, net	516		59		1,533		889
Total interest cost recognized	$	51,415	$	41,829	$	154,355	$	127,669

XML

LEASES

9 Months Ended

Mar. 28, 2021

Leases [Abstract]

LEASES

LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company had leases regarding certain improved properties in Fremont and Livermore, California (the “California Facility Leases”) that were classified as operating leases as of June 28, 2020. On September 21, 2020, the Company renewed these leases for an additional seven-year term, and concluded the modified leases are finance leases, and recognized approximately $31.4 million of property and equipment, net, for the associated right of use assets, and $29.8 million of finance lease obligations ($3.1 million classified in current portion of long-term debt and finance lease obligations and the remainder in long-term debt and finance lease obligations, less current portion). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 28, 2021.

During the term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

LEASES

LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company had leases regarding certain improved properties in Fremont and Livermore, California (the “California Facility Leases”) that were classified as operating leases as of June 28, 2020. On September 21, 2020, the Company renewed these leases for an additional seven-year term, and concluded the modified leases are finance leases, and recognized approximately $31.4 million of property and equipment, net, for the associated right of use assets, and $29.8 million of finance lease obligations ($3.1 million classified in current portion of long-term debt and finance lease obligations and the remainder in long-term debt and finance lease obligations, less current portion). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 28, 2021.

During the term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Mar. 28, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Refer to Note 13 - Leases for details regarding guarantees surrounding selected leases.

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of March 28, 2021, the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of March 28, 2021, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $73.2 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid.

In addition, the Company has entered into indemnification agreements with its officers and directors, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. As of March 28, 2021, warranty reserves totaling $16.4 million were recognized in other long-term liabilities, the remainder were included in accrued expenses and other current liabilities in the Company’s Condensed Consolidated Balance Sheets.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Balance at beginning of period	$	153,214	$	118,193	$	129,197	$	127,932
Warranties issued during the period	60,223		44,898		163,869		115,798
Settlements made during the period	(45,792)		(31,647)		(123,462)		(98,563)
Changes in liability for pre-existing warranties	4,801		(1,252)		2,842		(14,975)
Balance at end of period	$	172,446	$	130,192	$	172,446	$	130,192

Legal Proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.

XML

STOCK REPURCHASE PROGRAM

9 Months Ended

Mar. 28, 2021

Equity [Abstract]

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAMIn November 2020, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 28, 2020						$	1,773,427
Quarter ended September 27, 2020	1,344	$	461,998	$	343.73	$	1,311,429
Board authorization, $5 billion increase, November 2020						$	6,311,429
Quarter ended December 27, 2020	1,789	$	724,485	$	404.98	$	5,586,944
Quarter ended March 28, 2021	1,474	$	925,099	$	519.30	$	4,661,845

(1) Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 28, 2021.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and nine months ended March 28, 2021, the Company acquired 257 thousand shares at a total cost of $152.3 million and 280 thousand shares at a total cost of $160.6 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

Accelerated Share Repurchase Agreements

On February 11, 2021, the Company entered into an accelerated share repurchase agreement (the “February 2021 ASR") with a financial institution to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 655 thousand shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on February 11, 2021. The total number of shares received under the February 2021 ASR will be based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the February 2021 ASR will occur no later than June 9, 2021.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Mar. 28, 2021

Equity [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive loss, net of tax at March 28, 2021, as well as the activity for the nine months ending March 28, 2021, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges			Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments			Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 28, 2020	$	(45,811)	$	(32,796)		$	4,923		$	(20,527)	$	(94,211)
Other comprehensive income (loss) before reclassifications	20,231		12,546			(3,667)			234		29,344
Losses reclassified from accumulated other comprehensive loss to net income	—		843		(1)	727		(2)	—		1,570
Net current-period other comprehensive income (loss)	20,231		13,389			(2,940)			234		30,914
Balance at March 28, 2021	$	(25,580)	$	(19,407)		$	1,983		$	(20,293)	$	(63,297)

(1) Amount of after-tax loss reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

(2) Amount of after-tax loss reclassified from accumulated other comprehensive income into net income located in other expense, net.

XML

BASIS OF PRESENTATION (Policies)

9 Months Ended

Mar. 28, 2021

Accounting Policies [Abstract]

Consolidation

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Fiscal Period

The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 27, 2021 and includes 52 weeks.

Recent Accounting Pronouncements

Recently Adopted

In June 2016, the Financial Accounting Standards Board (“FASB”) released Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326).” The amendment revises the impairment model to utilize an expected loss methodology in place of the previously used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The FASB issued a subsequent amendment to the initial guidance in April 2019 and November 2019 within ASU 2019-04 and ASU 2019-11, respectively. The adoption of these standards in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In November 2018, the FASB issued ASU 2018-18, “Collaborative Arrangements (Topic 808).” The amendment clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606 when the counterparty is a customer for a good or service that is a distinct unit of account. The amendment also precludes entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The adoption of this standard in the first quarter of fiscal year 2021 did not have a material impact on the Company’s Condensed Consolidated Financial Statements.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “ Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. ASU 2020-04 became effective upon issuance and may be applied prospectively to contract modifications made on or before December 31, 2022. ASU 2021-01 became effective upon issuance and may be applied on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 or prospectively for contract modifications made on or before December 31, 2022. The Company has not yet applied the relief afforded by these standard amendments and is currently assessing contracts that will require modification due to reference rate reform to which these standard amendments may be applied.

Updates Not Yet Adopted or EffectiveIn August 2020, the FASB issued ASU No. 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. ASU 2020-06 also eliminates the treasury stock method to calculate diluted earnings per share and requires the if-converted method. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is required to adopt this standard in the first quarter of fiscal year 2023. The update permits the use of either the modified retrospective or fully retrospective method of transition. The Company does not expect adoption of this standard to have a material impact on its Consolidated Financial Statements related to the Company’s existing 2041 Notes (as defined in Note 12 - Long-Term Debt and Other Borrowings ).

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

XML

REVENUE (Tables)

9 Months Ended

Mar. 28, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Contract Transaction Price not yet Recognized as Revenue

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 28, 2021 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years		Total
	(In thousands)
Deferred revenue	$	661,240	$	156,040	(1)	$	—	$	817,280

(1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Disaggregation of Revenue

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
System revenue	$	2,545,306	$	1,647,560	$	7,000,968	$	4,759,881
Customer support-related revenue and other	1,302,348		856,065		3,480,003		2,492,991
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(In thousands)
China	$	1,217,427	$	792,412	$	3,600,281	$	2,142,366
Korea	1,195,711		589,072		2,664,493		1,503,733
Taiwan	545,719		515,485		1,576,109		1,587,848
Japan	262,913		239,751		999,462		721,664
Southeast Asia	260,360		62,800		829,157		460,723
United States	184,887		215,015		460,271		622,399
Europe	180,637		89,090		351,198		214,139
	$	3,847,654	$	2,503,625	$	10,480,971	$	7,252,872

Schedule of System Revenues of Primary Markets

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Memory	62	%	56	%	62	%	57	%
Foundry	31	%	31	%	31	%	31	%
Logic/integrated device manufacturing	7	%	13	%	7	%	12	%

XML

EQUITY-BASED COMPENSATION PLANS (Tables)

9 Months Ended

Mar. 28, 2021

Share-based Payment Arrangement [Abstract]

Recognized Equity Based Compensation Expense and Related Income Tax Benefit

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Equity-based compensation expense	$	55,746	$	47,414	$	163,843	$	136,044
Income tax benefit recognized related to equity-based compensation expense	$	44,077	$	24,457	$	63,866	$	38,736

XML

OTHER EXPENSE, NET (Tables)

9 Months Ended

Mar. 28, 2021

Other Income and Expenses [Abstract]

Components of Other Expense, Net

The significant components of other expense, net, are as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Interest income	$	4,209	$	18,856	$	15,964	$	76,094
Interest expense	(52,236)		(41,580)		(156,902)		(128,190)
Gains (losses) on deferred compensation plan-related assets, net	7,520		(33,828)		44,654		(20,135)
Foreign exchange gains (losses), net	541		480		(4,597)		(2,336)
Other, net	4,646		(8,547)		(3,172)		(16,704)
	$	(35,320)	$	(64,619)	$	(104,053)	$	(91,271)

XML

INCOME TAX EXPENSE (Tables)

9 Months Ended

Mar. 28, 2021

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rate Reconciliation

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 28, 2021			March 29, 2020			March 28, 2021			March 29, 2020
	(in thousands, except percentages)
Income tax expense	$	88,867		$	54,714		$	298,242		$	271,729
Effective tax rate	7.7		%	8.7		%	9.7		%	14.9		%

XML

NET INCOME PER SHARE (Tables)

9 Months Ended

Mar. 28, 2021

Earnings Per Share [Abstract]

Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share

The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands, except per share data)
Numerator:
Net income	$	1,071,121	$	574,781	$	2,763,801	$	1,555,080
Denominator:
Basic average shares outstanding	142,676		145,301		143,925		144,654
Effect of potential dilutive securities:
Employee stock plans	1,415		1,453		1,273		1,390
Convertible notes	518		1,411		725		3,604
Diluted average shares outstanding	144,609		148,165		145,923		149,648
Net income per share - basic	$	7.51	$	3.96	$	19.20	$	10.75
Net income per share - diluted	$	7.41	$	3.88	$	18.94	$	10.39

Schedule of Potentially Dilutive Securities Excluded from EPS Calculations

The following potentially dilutive securities were excluded:

	Three Months Ended		Nine Months Ended
	March 28, 2021	March 29, 2020	March 28, 2021	March 29, 2020
	(in thousands)
Options and RSUs	120	40	40	13

XML

FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Mar. 28, 2021

Fair Value Disclosures [Abstract]

Schedule of Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 28, 2021, and June 28, 2020:

	March 28, 2021
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	753,473	$	—	$	—	$	753,473	$	750,040	$	—	$	3,433	$	—
Time deposits	1,349,934		—		—		1,349,934		1,099,907		—		250,027		—
Level 1:
Money market funds	1,638,280		—		—		1,638,280		1,638,280		—		—		—
U.S. Treasury and agencies	385,461		209		(13)		385,657		—		385,657		—		—
Mutual funds	84,377		10,471		(105)		94,743		—		—		—		94,743
Level 1 Total	2,108,118		10,680		(118)		2,118,680		1,638,280		385,657		—		94,743
Level 2:
Government-sponsored enterprises	3,500		12		—		3,512		—		3,512		—		—
Foreign government bonds	47,099		43		(1)		47,141		—		47,141		—		—
Corporate notes and bonds	1,844,375		2,569		(633)		1,846,311		185,139		1,661,172		—		—
Mortgage backed securities — residential	6,279		74		—		6,353		—		6,353		—		—
Mortgage backed securities — commercial	12,264		33		(31)		12,266		—		12,266		—		—
Level 2 Total	1,913,517		2,731		(665)		1,915,583		185,139		1,730,444		—		—
Total	$	6,125,042	$	13,411	$	(783)	$	6,137,670	$	3,673,366	$	2,116,101	$	253,460	$	94,743

	June 28, 2020
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	977,862	$	—	$	—	$	977,862	$	973,978	$	—	$	3,884	$	—
Time deposits	2,244,655		—		—		2,244,655		1,994,628		—		250,027		—
Level 1:
Money market funds	1,709,350		—		—		1,709,350		1,709,350		—		—		—
U.S. Treasury and agencies	552,088		373		(9)		552,452		76,992		475,460		—		—
Mutual funds	68,784		4,571		(928)		72,427		—		—		—		72,427
Level 1 Total	2,330,222		4,944		(937)		2,334,229		1,786,342		475,460		—		72,427
Level 2:
Government-sponsored enterprises	31,442		12		—		31,454		25,999		5,455		—		—
Foreign government bonds	10,693		28		(5)		10,716		2,540		8,176		—		—
Corporate notes and bonds	1,405,615		5,344		(302)		1,410,657		131,685		1,278,972		—		—
Mortgage backed securities — residential	3,142		71		—		3,213		—		3,213		—		—
Mortgage backed securities — commercial	23,660		144		—		23,804		—		23,804		—		—
Level 2 Total	1,474,552		5,599		(307)		1,479,844		160,224		1,319,620		—		—
Total	$	7,027,291	$	10,543	$	(1,244)	$	7,036,590	$	4,915,172	$	1,795,080	$	253,911	$	72,427

Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments in Unrealized Loss Positions

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions; as of March 28, 2021 there are no unrealized loss positions with a duration equal to or greater than twelve months:

	March 28, 2021
	Unrealized Losses Less than 12 Months
	Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	7,958	$	(13)
Municipal notes and bonds	6,468		(105)
Foreign government bonds	21,259		(1)
Corporate notes and bonds	540,915		(633)
Mortgage backed securities — commercial	7,599		(31)
	$	584,199	$	(783)

Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, Restricted Cash and Investments with Contractual Maturities

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 28, 2021:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,270,859	$	4,271,415
Due after one year through five years	967,417		969,055
Due in more than five years	48,916		48,984
	$	5,287,192	$	5,289,454

Schedule of Total Notional Value of Cash Flow and Balance Sheet Hedge Instruments

The following table provides the total notional value of cash flow hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	328,737
Sell Contracts	352,034

The following table provides the total notional value of balance sheet hedge instruments outstanding as of March 28, 2021:

	March 28, 2021
	(In thousands)
Buy Contracts	$	150,554
Sell Contracts	154,595

Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”), was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021				March 28, 2021
	Location of  Gain or (Loss) Recognized in or Reclassified into Net Income	Gain (Loss) Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income		Gain Recognized in AOCI		(Loss) Gain Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	15,285	$	(1,323)	$	6,948	$	(3,598)
Foreign Exchange Contracts	Cost of goods sold	(3,473)		1,355		3,429		3,073
Foreign Exchange Contracts	Research and Development	(1,319)		—		950		—
Foreign Exchange Contracts	Selling, general, and administrative	(1,741)		1,326		4,056		2,649
Interest Rate Contracts	Other expense, net	—		(962)		—		(2,871)
		$	8,752	$	396	$	15,383	$	(747)

		Three Months Ended				Nine Months Ended
		March 29, 2020				March 29, 2020
	Location of  Gain or (Loss) Recognized in or Reclassified into Income	Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income		Gain (Loss) Recognized in AOCI		Gain (Loss) Reclassified from AOCI into Net Income
Derivatives in Cash Flow Hedging Relationships		(in thousands)
Foreign Exchange Contracts	Revenue	$	6,334	$	1,279	$	9,532	$	773
Foreign Exchange Contracts	Cost of goods sold	(2,589)		(186)		(3,656)		(2,086)
Foreign Exchange Contracts	Selling, general, and administrative	(1,394)		6		(1,859)		(887)
Interest Rate Contracts	Other expense, net	(40,901)		(36)		(38,507)		(106)
		$	(38,550)	$	1,063	$	(34,490)	$	(2,306)

The effect of the Company’s balance sheet hedge derivative instruments on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended				Nine Months Ended
		March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Net Income		Loss Recognized in Net Income		Gain Recognized in Net Income		Loss Recognized in Net Income
		(in thousands)
Foreign Exchange Contracts	Other expense, net	$	2,992	$	(6,858)	$	6,895	$	(8,788)

XML

INVENTORIES (Tables)

9 Months Ended

Mar. 28, 2021

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Raw materials	$	1,437,563	$	1,161,961
Work-in-process	359,402		251,199
Finished goods	755,067		486,864
	$	2,552,032	$	1,900,024

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Mar. 28, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The following table provides the Company’s intangible assets, other than goodwill:

	March 28, 2021						June 28, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	630,278	$	(569,203)	$	61,075	$	630,137	$	(532,550)	$	97,587
Existing technology	669,302		(658,632)		10,670		668,992		(654,382)		14,610
Patents and other intangible assets	125,383		(53,864)		71,519		98,342		(42,007)		56,335
Total intangible assets	$	1,424,963	$	(1,281,699)	$	143,264	$	1,397,471	$	(1,228,939)	$	168,532

Estimated Future Amortization Expense of Intangible Assets

The estimated future amortization expense of intangible assets as of March 28, 2021, is reflected in the table below. The table excludes $13.9 million of capitalized costs for internal-use software that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2021 (remaining 3 months)	$	18,019
2022	68,138
2023	22,274
2024	12,089
2025	6,681
Thereafter	2,164
	$	129,365

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

9 Months Ended

Mar. 28, 2021

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	March 28, 2021		June 28, 2020
	(in thousands)
Accrued compensation	$	442,188	$	402,401
Warranty reserves	156,059		117,839
Income and other taxes payable	99,021		215,652
Dividend payable	185,390		167,129
Other	409,516		369,634
	$	1,292,174	$	1,272,655

XML

LONG-TERM DEBT AND OTHER BORROWINGS (Tables)

9 Months Ended

Mar. 28, 2021

Debt Disclosure [Abstract]

Schedule of Outstanding Debt

As of March 28, 2021, and June 28, 2020, the Company’s outstanding debt consisted of the following:

	March 28, 2021					June 28, 2020
	Amount (in thousands)			Effective Interest Rate		Amount (in thousands)			Effective Interest Rate
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000			2.95	%	800,000			2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000			3.87	%	500,000			3.87	%
Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes")	750,000			3.86	%	750,000			3.86	%
Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes")	1,000,000			4.09	%	1,000,000			4.09	%
Fixed-rate 1.90% Senior Note Due June 15, 2030 ("2030 Notes")	750,000			2.01	%	750,000			2.01	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	17,289		(1)	4.28	%	48,460		(1)	4.28	%
Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes")	750,000			4.93	%	750,000			4.93	%
Fixed-rate 2.875% Senior Note Due June 15, 2050 ("2050 Notes")	750,000			2.93	%	750,000			2.93	%
Fixed-rate 3.125% Senior Note Due June 15, 2060 ("2060 Notes")	500,000			3.18	%	500,000			3.18	%
Total debt outstanding, at par	5,817,289					5,848,460
Unamortized discount	(42,443)					(53,086)
Fair value adjustment - interest rate contracts	7,066		(2)			8,405		(2)
Unamortized bond issuance costs	(7,649)					(8,301)
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478
Reported as:
Current portion of long-term debt	$	813,786				$	836,107
Long-term debt	4,960,477					4,959,371
Total debt outstanding, at carrying value	$	5,774,263				$	5,795,478

____________________________

(1) As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Condensed Consolidated Balance Sheets. Additionally, on March 26, 2021, the Company issued a notice of redemption to the existing bondholders, with a redemption date of May 21, 2021.

(2) This amount represents a cumulative fair value gain for discontinued hedging relationships, net of an immaterial amount of amortization as of the periods presented.

Components of Convertible Notes

Selected additional information regarding the 2041 Notes outstanding as of March 28, 2021, and June 28, 2020, is as follows:

	March 28, 2021		June 28, 2020
	2041 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	161,612	$	161,467
Carrying amount of temporary equity component, net of tax	$	3,217	$	10,995
Remaining amortization period (years)	20.1		20.9
Fair Value of Notes (Level 2)	$	319,495
Conversion rate (shares of common stock per $1,000 principal amount of notes)	31.8009
Conversion price (per share of common stock)	$	31.45
If-converted value in excess of par value	$	303,924
Estimated share dilution using average quarterly stock price $538.79 per share	518

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments

Selected additional information regarding the Senior Notes outstanding as of March 28, 2021, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2021 Notes	0.2	$	802,480
2025 Notes	4.0	$	550,435
2026 Notes	5.0	$	835,095
2029 Notes	8.0	$	1,139,390
2030 Notes	9.2	$	729,968
2049 Notes	28.0	$	973,500
2050 Notes	29.2	$	711,263
2060 Notes	39.2	$	484,215

Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, commercial paper, and the revolving credit facility during the three and nine months ended March 28, 2021 and March 29, 2020.

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Contractual interest coupon	$	49,487	$	40,409	$	148,573	$	122,196
Amortization of interest discount	998		953		3,011		3,346
Amortization of issuance costs	414		408		1,238		1,238
Effect of interest rate contracts, net	516		59		1,533		889
Total interest cost recognized	$	51,415	$	41,829	$	154,355	$	127,669

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Mar. 28, 2021

Commitments and Contingencies Disclosure [Abstract]

Schedule of Warranties

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 28, 2021		March 29, 2020		March 28, 2021		March 29, 2020
	(in thousands)
Balance at beginning of period	$	153,214	$	118,193	$	129,197	$	127,932
Warranties issued during the period	60,223		44,898		163,869		115,798
Settlements made during the period	(45,792)		(31,647)		(123,462)		(98,563)
Changes in liability for pre-existing warranties	4,801		(1,252)		2,842		(14,975)
Balance at end of period	$	172,446	$	130,192	$	172,446	$	130,192

XML

STOCK REPURCHASE PROGRAM (Tables)

9 Months Ended

Mar. 28, 2021

Equity [Abstract]

Repurchases Under the Repurchase Program

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 28, 2020						$	1,773,427
Quarter ended September 27, 2020	1,344	$	461,998	$	343.73	$	1,311,429
Board authorization, $5 billion increase, November 2020						$	6,311,429
Quarter ended December 27, 2020	1,789	$	724,485	$	404.98	$	5,586,944
Quarter ended March 28, 2021	1,474	$	925,099	$	519.30	$	4,661,845

(1) Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 28, 2021.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Mar. 28, 2021

Equity [Abstract]

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax at March 28, 2021, as well as the activity for the nine months ending March 28, 2021, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges			Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments			Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 28, 2020	$	(45,811)	$	(32,796)		$	4,923		$	(20,527)	$	(94,211)
Other comprehensive income (loss) before reclassifications	20,231		12,546			(3,667)			234		29,344
Losses reclassified from accumulated other comprehensive loss to net income	—		843		(1)	727		(2)	—		1,570
Net current-period other comprehensive income (loss)	20,231		13,389			(2,940)			234		30,914
Balance at March 28, 2021	$	(25,580)	$	(19,407)		$	1,983		$	(20,293)	$	(63,297)

(1) Amount of after-tax loss reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

(2) Amount of after-tax loss reclassified from accumulated other comprehensive income into net income located in other expense, net.

XML

REVENUE - Additional Information (Details) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 28, 2021 USD ($) segment region market	Mar. 28, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Revenue recognized | $	$ 69.1	$ 427.2
Number reportable business segment | segment	1
Number of operating geographic regions | region	7
Number of primary markets | market	3

XML

REVENUE - Summary of Contract Transaction Price not yet Recognized as Revenue (Details) $ in Thousands	Mar. 28, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 817,280
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-03-29
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 661,240
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of satisfaction	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-06-28
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 156,040
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of satisfaction	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-06-24
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of satisfaction

XML

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 3,847,654	$ 2,503,625	$ 10,480,971	$ 7,252,872
China
Disaggregation of Revenue [Line Items]
Revenue	1,217,427	792,412	3,600,281	2,142,366
Korea
Disaggregation of Revenue [Line Items]
Revenue	1,195,711	589,072	2,664,493	1,503,733
Taiwan
Disaggregation of Revenue [Line Items]
Revenue	545,719	515,485	1,576,109	1,587,848
Japan
Disaggregation of Revenue [Line Items]
Revenue	262,913	239,751	999,462	721,664
Southeast Asia
Disaggregation of Revenue [Line Items]
Revenue	260,360	62,800	829,157	460,723
United States
Disaggregation of Revenue [Line Items]
Revenue	184,887	215,015	460,271	622,399
Europe
Disaggregation of Revenue [Line Items]
Revenue	180,637	89,090	351,198	214,139
System revenue
Disaggregation of Revenue [Line Items]
Revenue	2,545,306	1,647,560	7,000,968	4,759,881
Customer support-related revenue and other
Disaggregation of Revenue [Line Items]
Revenue	$ 1,302,348	$ 856,065	$ 3,480,003	$ 2,492,991

XML

REVENUE - Schedule of System Revenues of Primary Markets (Details) - Equipment and upgrade revenue	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Memory
Concentration Risk [Line Items]
Primary market revenue, percent	62.00%	56.00%	62.00%	57.00%
Foundry
Concentration Risk [Line Items]
Primary market revenue, percent	31.00%	31.00%	31.00%	31.00%
Logic/integrated device manufacturing
Concentration Risk [Line Items]
Primary market revenue, percent	7.00%	13.00%	7.00%	12.00%

XML

EQUITY-BASED COMPENSATION PLANS - Additional Information (Details)	3 Months Ended
	Mar. 28, 2021
Share-based Payment Arrangement [Abstract]
Vesting period (in years)	3 years

XML

EQUITY-BASED COMPENSATION PLANS - Recognized Equity-Based Compensation Expenses and Related Income Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Share-based Payment Arrangement [Abstract]
Equity-based compensation expense	$ 55,746	$ 47,414	$ 163,843	$ 136,044
Income tax benefit recognized related to equity-based compensation expense	$ 44,077	$ 24,457	$ 63,866	$ 38,736

XML

OTHER EXPENSE, NET (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Other Income and Expenses [Abstract]
Interest income	$ 4,209	$ 18,856	$ 15,964	$ 76,094
Interest expense	(52,236)	(41,580)	(156,902)	(128,190)
Gains (losses) on deferred compensation plan-related assets, net	7,520	(33,828)	44,654	(20,135)
Foreign exchange gains (losses), net	541	480	(4,597)	(2,336)
Other, net	4,646	(8,547)	(3,172)	(16,704)
Other expense, net	$ (35,320)	$ (64,619)	$ (104,053)	$ (91,271)

XML

INCOME TAX EXPENSE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 88,867	$ 54,714	$ 298,242	$ 271,729
Effective tax rate	7.70%	8.70%	9.70%	14.90%
Tax examinations or lapses of statute of limitation
Income Tax Contingency [Line Items]
Estimated unrecognized tax benefits reduction	$ 7,400		$ 7,400

XML

NET INCOME PER SHARE - Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Numerator:
Net income	$ 1,071,121	$ 574,781	$ 2,763,801	$ 1,555,080
Denominator:
Basic average shares outstanding (in shares)	142,676	145,301	143,925	144,654
Effect of potential dilutive securities:
Employee stock plans (in shares)	1,415	1,453	1,273	1,390
Convertible notes (in shares)	518	1,411	725	3,604
Diluted average shares outstanding (in shares)	144,609	148,165	145,923	149,648
Net income per share - basic (in dollars per share)	$ 7.51	$ 3.96	$ 19.20	$ 10.75
Net income per share - diluted (in dollars per share)	$ 7.41	$ 3.88	$ 18.94	$ 10.39

XML

NET INCOME PER SHARE - Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of potentially dilutive securities (in shares)	120	40	40	13

XML

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020		Mar. 29, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	$ 5,287,192
Total cost	6,125,042	$ 7,027,291
Total, unrealized gain	13,411	10,543
Total unrealized (loss)	(783)	(1,244)
Total fair value	6,137,670	7,036,590
Cash and Cash Equivalents	3,673,366	4,915,172	[1]	$ 3,961,586
Investments	2,116,101	1,795,080	[1]
Restricted cash and investments	253,460	253,911	[1]
Other Assets	94,743	72,427
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total cost	2,108,118	2,330,222
Total, unrealized gain	10,680	4,944
Total unrealized (loss)	(118)	(937)
Total fair value	2,118,680	2,334,229
Cash and Cash Equivalents	1,638,280	1,786,342
Investments	385,657	475,460
Restricted cash and investments	0	0
Other Assets	94,743	72,427
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total cost	1,913,517	1,474,552
Total, unrealized gain	2,731	5,599
Total unrealized (loss)	(665)	(307)
Total fair value	1,915,583	1,479,844
Cash and Cash Equivalents	185,139	160,224
Investments	1,730,444	1,319,620
Restricted cash and investments	0	0
Other Assets	0	0
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents at fair value	753,473	977,862
Cash and Cash Equivalents	750,040	973,978
Investments	0	0
Restricted cash and investments	3,433	3,884
Other Assets	0	0
Time deposits
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents at fair value	1,349,934	2,244,655
Cash and Cash Equivalents	1,099,907	1,994,628
Investments	0	0
Restricted cash and investments	250,027	250,027
Other Assets	0	0
Money market funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	1,638,280	1,709,350
Debt securities, unrealized gain	0	0
Debt securities, unrealized (loss)	0	0
Debt securities, fair value	1,638,280	1,709,350
Cash and Cash Equivalents	1,638,280	1,709,350
Investments	0	0
Restricted cash and investments	0	0
Other Assets	0	0
U.S. Treasury and agencies | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	385,461	552,088
Debt securities, unrealized gain	209	373
Debt securities, unrealized (loss)	(13)	(9)
Debt securities, fair value	385,657	552,452
Cash and Cash Equivalents	0	76,992
Investments	385,657	475,460
Restricted cash and investments	0	0
Other Assets	0	0
Mutual funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities, cost	84,377	68,784
Trading securities, unrealized gain	10,471	4,571
Trading securities, unrealized (loss)	(105)	(928)
Trading securities, fair value	94,743	72,427
Cash and Cash Equivalents	0	0
Investments	0	0
Restricted cash and investments	0	0
Other Assets	94,743	72,427
Government-sponsored enterprises | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	3,500	31,442
Debt securities, unrealized gain	12	12
Debt securities, unrealized (loss)	0	0
Debt securities, fair value	3,512	31,454
Cash and Cash Equivalents	0	25,999
Investments	3,512	5,455
Restricted cash and investments	0	0
Other Assets	0	0
Foreign government bonds | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	47,099	10,693
Debt securities, unrealized gain	43	28
Debt securities, unrealized (loss)	(1)	(5)
Debt securities, fair value	47,141	10,716
Cash and Cash Equivalents	0	2,540
Investments	47,141	8,176
Restricted cash and investments	0	0
Other Assets	0	0
Corporate notes and bonds | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	1,844,375	1,405,615
Debt securities, unrealized gain	2,569	5,344
Debt securities, unrealized (loss)	(633)	(302)
Debt securities, fair value	1,846,311	1,410,657
Cash and Cash Equivalents	185,139	131,685
Investments	1,661,172	1,278,972
Restricted cash and investments	0	0
Other Assets	0	0
Mortgage backed securities — residential | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	6,279	3,142
Debt securities, unrealized gain	74	71
Debt securities, unrealized (loss)	0	0
Debt securities, fair value	6,353	3,213
Cash and Cash Equivalents	0	0
Investments	6,353	3,213
Restricted cash and investments	0	0
Other Assets	0	0
Mortgage backed securities — commercial | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	12,264	23,660
Debt securities, unrealized gain	33	144
Debt securities, unrealized (loss)	(31)	0
Debt securities, fair value	12,266	23,804
Cash and Cash Equivalents	0	0
Investments	12,266	23,804
Restricted cash and investments	0	0
Other Assets	$ 0	$ 0

[1] Derived from audited financial statements

XML

FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Fair Value Disclosures [Abstract]
Other than temporary impairment losses, investments		$ 0
Derivative Instruments, Gain (Loss) [Line Items]
Insignificant realized gains/losses	$ 0	$ 0	$ 0	$ 0
Cash Flow Hedges | Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	12 months
Cash Flow Hedges | Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	24 months

XML

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments Unrealized Loss Positions (Details) $ in Thousands	Mar. 28, 2021 USD ($)
Fair Value
Unrealized Losses Less than 12 Months	$ 584,199
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(783)
U.S. Treasury and agencies
Fair Value
Unrealized Losses Less than 12 Months	7,958
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(13)
Municipal notes and bonds
Fair Value
Unrealized Losses Less than 12 Months	6,468
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(105)
Foreign government bonds
Fair Value
Unrealized Losses Less than 12 Months	21,259
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(1)
Corporate notes and bonds
Fair Value
Unrealized Losses Less than 12 Months	540,915
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(633)
Mortgage backed securities — commercial
Fair Value
Unrealized Losses Less than 12 Months	7,599
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	$ (31)

XML

FINANCIAL INSTRUMENTS - Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, and Restricted Cash and Investments with Contractual Maturities (Details) $ in Thousands	Mar. 28, 2021 USD ($)
Cost
Due in one year or less	$ 4,270,859
Due after one year through five years	967,417
Due in more than five years	48,916
Debt securities, cost	5,287,192
Fair Value
Due in one year or less	4,271,415
Due after one year through five years	969,055
Due in more than five years	48,984
Total	$ 5,289,454

XML

FINANCIAL INSTRUMENTS - Schedule of Total Notional Value of Cash Flow and Balance Sheet Hedge Instruments (Details) - Foreign Exchange Contract - Foreign currency forward contracts $ in Thousands	Mar. 28, 2021 USD ($)
Designated as Hedging Instrument | Buy Contracts
Derivative [Line Items]
Derivative notional amount	$ 328,737
Designated as Hedging Instrument | Sell Contracts
Derivative [Line Items]
Derivative notional amount	352,034
Derivatives not designated as hedging instruments | Buy Contracts
Derivative [Line Items]
Derivative notional amount	150,554
Derivatives not designated as hedging instruments | Sell Contracts
Derivative [Line Items]
Derivative notional amount	$ 154,595

XML

FINANCIAL INSTRUMENTS - Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Foreign Exchange Contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	$ 8,752	$ (38,550)	$ 15,383	$ (34,490)
(Loss) Gain Reclassified from AOCI into Net Income	396	1,063	(747)	(2,306)
Foreign Exchange Contracts | Revenue
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	15,285	6,334	6,948	9,532
(Loss) Gain Reclassified from AOCI into Net Income	(1,323)	1,279	(3,598)	773
Foreign Exchange Contracts | Cost of goods sold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	(3,473)	(2,589)	3,429	(3,656)
(Loss) Gain Reclassified from AOCI into Net Income	1,355	(186)	3,073	(2,086)
Foreign Exchange Contracts | Research and Development
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	(1,319)		950
(Loss) Gain Reclassified from AOCI into Net Income	0		0
Foreign Exchange Contracts | Selling, general, and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	(1,741)	(1,394)	4,056	(1,859)
(Loss) Gain Reclassified from AOCI into Net Income	1,326	6	2,649	(887)
Foreign Exchange Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in Net Income	2,992	(6,858)	6,895	(8,788)
Interest Rate Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	0	(40,901)	0	(38,507)
(Loss) Gain Reclassified from AOCI into Net Income	$ (962)	$ (36)	$ (2,871)	$ (106)

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 1,437,563	$ 1,161,961
Work-in-process	359,402	251,199
Finished goods	755,067	486,864
Total inventories	$ 2,552,032	$ 1,900,024	[1]

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020	Jun. 28, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,489,990		$ 1,489,990		$ 1,484,436	[1]
Tax deductible goodwill	61,100		61,100		$ 61,100
Intangible asset amortization expense	17,900	$ 16,600	52,300	$ 49,300
Capitalized costs for internal-use software	$ 13,900		$ 13,900

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,424,963	$ 1,397,471
Accumulated Amortization	(1,281,699)	(1,228,939)
Net	143,264	168,532	[1]
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	630,278	630,137
Accumulated Amortization	(569,203)	(532,550)
Net	61,075	97,587
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross	669,302	668,992
Accumulated Amortization	(658,632)	(654,382)
Net	10,670	14,610
Patents and other intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross	125,383	98,342
Accumulated Amortization	(53,864)	(42,007)
Net	$ 71,519	$ 56,335

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Estimated Future Amortization Expense of Intangible Assets (Details) $ in Thousands	Mar. 28, 2021 USD ($)
Fiscal Year
2021 (remaining 3 months)	$ 18,019
2022	68,138
2023	22,274
2024	12,089
2025	6,681
Thereafter	2,164
Net	$ 129,365

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 28, 2021	Jun. 28, 2020
Payables and Accruals [Abstract]
Accrued compensation	$ 442,188	$ 402,401
Warranty reserves	156,059	117,839
Income and other taxes payable	99,021	215,652
Dividend payable	185,390	167,129
Other	409,516	369,634
Accrued expenses and other current liabilities	$ 1,292,174	$ 1,272,655	[1]

[1] Derived from audited financial statements

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt (Details) $ in Thousands	9 Months Ended
	Mar. 28, 2021 USD ($) d	Jun. 28, 2020 USD ($)	May 05, 2020	Mar. 04, 2019	Jun. 07, 2016	Mar. 12, 2015	Jun. 30, 2012
Debt Instrument [Line Items]
Total debt outstanding, at par	$ 5,817,289	$ 5,848,460
Unamortized discount	(42,443)	(53,086)
Fair value adjustment - interest rate contracts	7,066	8,405
Unamortized bond issuance costs	(7,649)	(8,301)
Total debt outstanding, at carrying value	5,774,263	5,795,478
Current portion of long-term debt	813,786	836,107
Long-term debt	$ 4,960,477	$ 4,959,371
Senior notes | Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	2.80%				2.80%
Effective Interest Rate	2.95%	2.95%
Amount	$ 800,000	$ 800,000
Senior notes | Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	3.80%					3.80%
Effective Interest Rate	3.87%	3.87%
Amount	$ 500,000	$ 500,000
Senior notes | Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	3.75%			3.75%
Effective Interest Rate	3.86%	3.86%
Amount	$ 750,000	$ 750,000
Senior notes | Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	4.00%			4.00%
Effective Interest Rate	4.09%	4.09%
Amount	$ 1,000,000	$ 1,000,000
Senior notes | Fixed-rate 1.90% Senior Note Due June 15, 2030 ("2030 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	1.90%		1.90%
Effective Interest Rate	2.01%	2.01%
Amount	$ 750,000	$ 750,000
Senior notes | Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	4.875%			4.875%
Effective Interest Rate	4.93%	4.93%
Amount	$ 750,000	$ 750,000
Senior notes | Fixed-rate 2.875% Senior Note Due June 15, 2050 ("2050 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	2.875%		2.875%
Effective Interest Rate	2.93%	2.93%
Amount	$ 750,000	$ 750,000
Senior notes | Fixed-rate 3.125% Senior Note Due June 15, 2060 ("2060 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	3.125%		3.125%
Effective Interest Rate	3.18%	3.18%
Amount	$ 500,000	$ 500,000
Convertible debt | Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")
Debt Instrument [Line Items]
Senior notes interest rate	2.625%						2.625%
Effective Interest Rate	4.28%	4.28%
Amount	$ 17,289	$ 48,460
Stock price percentage of conversion price	130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter | d	20
Number of consecutive trading days period required | d	30

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Convertible Senior Notes (Details) - Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") - Convertible debt - USD ($)	1 Months Ended	3 Months Ended	4 Months Ended	9 Months Ended
	Jun. 30, 2012	Mar. 28, 2021	Apr. 28, 2021	Mar. 28, 2021	Jun. 28, 2020
Debt Instrument [Line Items]
Principal amount	$ 700,000,000
Senior notes interest rate	2.625%	2.625%		2.625%
Conversion of notes		$ 9,600,000		$ 31,200,000
Long-term debt		$ 17,289,000		$ 17,289,000	$ 48,460,000
Conversion of 2041 notes | Subsequent event
Debt Instrument [Line Items]
Conversion of notes			$ 0
Maximum
Debt Instrument [Line Items]
Maximum amount of contingent interest rate	0.60%

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Components of Convertible Senior Notes (Details) - Convertible debt - Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") $ / shares in Units, shares in Thousands	9 Months Ended	12 Months Ended
	Mar. 28, 2021 USD ($) $ / shares shares	Jun. 28, 2020 USD ($)
Debt Instrument [Line Items]
Remaining amortization period (years)	20 years 1 month 6 days	20 years 10 months 24 days
Fair Value of Notes (Level 2)	$ 319,495,000
Conversion rate (shares of common stock per $1,000 principal amount of notes)	$ 1,000
Conversion rate (shares of common stock per $1,000 principal amount of notes)	31.8009
Conversion price (per share of common stock) (in dollars per share) | $ / shares	$ 31.45
If-converted value in excess of par value	$ 303,924,000
Estimated share dilution using average quarterly stock price $538.79 per share | shares	518
Share price (in dollars per share) | $ / shares	$ 538.79
Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 161,612,000	$ 161,467,000
Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 3,217,000	$ 10,995,000

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Senior Notes (Details) - Senior notes - USD ($)	9 Months Ended
	Mar. 28, 2021	May 05, 2020	Mar. 04, 2019	Jun. 07, 2016	Mar. 12, 2015
Debt Instrument [Line Items]
Debt instrument, redemption price percent	100.00%
2030 Notes
Debt Instrument [Line Items]
Principal amount		$ 750,000,000
Senior notes interest rate	1.90%	1.90%
2050 Notes
Debt Instrument [Line Items]
Principal amount		$ 750,000,000
Senior notes interest rate	2.875%	2.875%
2060 Notes
Debt Instrument [Line Items]
Principal amount		$ 500,000,000
Senior notes interest rate	3.125%	3.125%
2026 Notes
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Senior notes interest rate	3.75%		3.75%
2029 Notes
Debt Instrument [Line Items]
Principal amount			$ 1,000,000,000.0
Senior notes interest rate	4.00%		4.00%
2049 Notes
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Senior notes interest rate	4.875%		4.875%
2025 Notes
Debt Instrument [Line Items]
Principal amount					$ 500,000,000
Senior notes interest rate	3.80%				3.80%
2021 Notes
Debt Instrument [Line Items]
Principal amount				$ 800,000,000
Senior notes interest rate	2.80%			2.80%
Debt instrument, redemption price upon occurrence of certain events, percent	101.00%

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Additional Senior Notes Information (Details) $ in Thousands	9 Months Ended
	Mar. 28, 2021 USD ($)
2021 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	2 months 12 days
2021 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 802,480
2025 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	4 years
2025 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 550,435
2026 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	5 years
2026 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 835,095
2029 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	8 years
2029 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 1,139,390
2030 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	9 years 2 months 12 days
2030 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 729,968
2049 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	28 years
2049 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 973,500
2050 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	29 years 2 months 12 days
2050 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 711,263
2060 Notes
Debt Instrument [Line Items]
Remaining amortization period (in years)	39 years 2 months 12 days
2060 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 484,215

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Revolving Credit Facility (Details) - Revolving credit facility - USD ($)	Feb. 25, 2019	Mar. 28, 2021
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility	$ 1,250,000,000
Additional increase in the facility, available expansion	600,000,000.0
Revolving unsecured credit facility, available expansion	$ 1,850,000,000
Borrowings outstanding		$ 0
Federal Funds Rate
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
One-month LIBOR
Extinguishment of Debt [Line Items]
Variable interest spread	1.00%
One-month LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.00%
One-month LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.90%
LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	1.50%

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Commercial Paper Program (Details) - Commercial paper - USD ($)	Mar. 28, 2021	Jun. 28, 2020	Nov. 13, 2017
Line of Credit Facility [Line Items]
Unsecured private placement commercial paper notes, maximum aggregate principal			$ 1,250,000,000
Borrowings outstanding	$ 0	$ 0

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Debt Disclosure [Abstract]
Contractual interest coupon	$ 49,487	$ 40,409	$ 148,573	$ 122,196
Amortization of interest discount	998	953	3,011	3,346
Amortization of issuance costs	414	408	1,238	1,238
Effect of interest rate contracts, net	516	59	1,533	889
Total interest cost recognized	$ 51,415	$ 41,829	$ 154,355	$ 127,669

XML

LEASES (Details) - USD ($)	Mar. 28, 2021	Sep. 21, 2020	Jun. 28, 2020	[1]
Guarantor Obligations [Line Items]
Restricted cash and investments	$ 253,460,000		$ 253,911,000
California Facility Leases
Guarantor Obligations [Line Items]
Lease renewal term		7 years
Right of use assets		$ 31,400,000
Finance lease obligations		29,800,000
Finance lease obligations, current		$ 3,100,000
California Facility Leases | Maximum
Guarantor Obligations [Line Items]
Residual value of operating lease, maximum	298,400,000
Operating Lease Cash Collateral
Guarantor Obligations [Line Items]
Restricted cash and investments	$ 250,000,000.0

[1] Derived from audited financial statements

XML

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($) $ in Thousands	Mar. 28, 2021	Dec. 27, 2020	Jun. 28, 2020	Mar. 29, 2020	Dec. 29, 2019	Jun. 30, 2019
Loss Contingencies [Line Items]
Warranty reserves	$ 172,446	$ 153,214	$ 129,197	$ 130,192	$ 118,193	$ 127,932
Other long-term liabilities
Loss Contingencies [Line Items]
Warranty reserves	16,400
Letters of Credit
Loss Contingencies [Line Items]
Guarantee obligation maximum exposure	$ 73,200

XML

COMMITMENTS AND CONTINGENCIES - Schedule of Changes in Product Warranty Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2021	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020
Changes in Product Warranty Reserve
Balance at beginning of period	$ 153,214	$ 118,193	$ 129,197	$ 127,932
Warranties issued during the period	60,223	44,898	163,869	115,798
Settlements made during the period	(45,792)	(31,647)	(123,462)	(98,563)
Changes in liability for pre-existing warranties	4,801	(1,252)	2,842	(14,975)
Balance at end of period	$ 172,446	$ 130,192	$ 172,446	$ 130,192

XML

STOCK REPURCHASE PROGRAM - Additional Information (Details) - USD ($) shares in Thousands		1 Months Ended	3 Months Ended			9 Months Ended
	Feb. 11, 2021	Nov. 30, 2020	Mar. 28, 2021	Dec. 27, 2020	Sep. 27, 2020	Mar. 28, 2021
Equity, Class of Treasury Stock [Line Items]
Net shares of settlements to cover tax withholding obligations (in shares)			257			280
Amount paid for shares under net share settlements			$ 152,300,000			$ 160,600,000
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Board authorized increase		$ 5,000,000,000
Total Number of Shares Repurchased (in shares)			1,474	1,789	1,344
February 2021 ASR
Equity, Class of Treasury Stock [Line Items]
Accelerated Share Repurchases, Authorized Amount	$ 500,000,000
Total Number of Shares Repurchased (in shares)	655
Percent of prepayment amount	75.00%

XML

STOCK REPURCHASE PROGRAM - Repurchases Under the Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands	1 Months Ended	3 Months Ended				9 Months Ended
	Nov. 30, 2020	Mar. 28, 2021	Dec. 27, 2020	Sep. 27, 2020	Mar. 29, 2020	Mar. 28, 2021	Mar. 29, 2020	Jun. 28, 2020
Equity, Class of Treasury Stock [Line Items]
Total Cost of Repurchase		$ 1,077,380,000			$ 245,439,000	$ 2,272,222,000	$ 1,328,898,000
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Board authorized increase	$ 5,000,000,000
Total Number of Shares Repurchased (in shares)		1,474	1,789	1,344
Total Cost of Repurchase		$ 925,099,000	$ 724,485,000	$ 461,998,000
Average Price Paid Per Share (in dollars per share)		$ 519.30	$ 404.98	$ 343.73
Amount Available Under Repurchase Program	$ 6,311,429,000	$ 4,661,845,000	$ 5,586,944,000	$ 1,311,429,000		$ 4,661,845,000		$ 1,773,427,000

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Details) $ in Thousands	9 Months Ended
	Mar. 28, 2021 USD ($)
Change in Accumulated Other Comprehensive Loss
Beginning balance	$ 5,172,494	[1]
Other comprehensive income (loss) before reclassifications	29,344
Losses reclassified from accumulated other comprehensive loss to net income	1,570
Net current-period other comprehensive income (loss)	30,914
Ending balance	5,371,616
Accumulated Foreign Currency Translation Adjustment
Change in Accumulated Other Comprehensive Loss
Beginning balance	(45,811)
Other comprehensive income (loss) before reclassifications	20,231
Losses reclassified from accumulated other comprehensive loss to net income	0
Net current-period other comprehensive income (loss)	20,231
Ending balance	(25,580)
Accumulated Unrealized  Gain or Loss on Cash flow hedges
Change in Accumulated Other Comprehensive Loss
Beginning balance	(32,796)
Other comprehensive income (loss) before reclassifications	12,546
Losses reclassified from accumulated other comprehensive loss to net income	843
Net current-period other comprehensive income (loss)	13,389
Ending balance	(19,407)
Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments
Change in Accumulated Other Comprehensive Loss
Beginning balance	4,923
Other comprehensive income (loss) before reclassifications	(3,667)
Losses reclassified from accumulated other comprehensive loss to net income	727
Net current-period other comprehensive income (loss)	(2,940)
Ending balance	1,983
Accumulated Unrealized  Components of Defined  Benefit Plans
Change in Accumulated Other Comprehensive Loss
Beginning balance	(20,527)
Other comprehensive income (loss) before reclassifications	234
Losses reclassified from accumulated other comprehensive loss to net income	0
Net current-period other comprehensive income (loss)	234
Ending balance	(20,293)
Total
Change in Accumulated Other Comprehensive Loss
Beginning balance	(94,211)
Ending balance	$ (63,297)

[1] Derived from audited financial statements

XML

Label	Element	Value
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 254,155,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	253,460,000
Dividends Payable	us-gaap_DividendsPayableCurrentAndNoncurrent	167,740,000
Dividends Payable	us-gaap_DividendsPayableCurrentAndNoncurrent	$ 185,390,000